Other/unspecified cytomegaloviral diseases

CMV_NOS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — B25.8, B25.8+G05.1, B25.9 Hospital discharge: ICD-9 — 0785X Hospital discharge: ICD-8 — 0795 Cause of death: ICD-10 — B25.8, B25.8+G05.1, B25.9 Cause of death: ICD-9 — 0785X Cause of death: ICD-8 — 0795 2 out of 7 registries used, show all original rules.	1017
4. Check minimum number of events None	1017
5. Include endpoints None	1017
6. Filter based on genotype QC (FinnGen only)	698

Control definitions (FinnGen only)

Control exclude: IBD_CMV

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	CMV_NOS
CONTROL_EXCLUDE	IBD_CMV
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	B25[8-9]
HD_ICD_9	0785X
HD_ICD_8	0795
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	B25[8-9]
COD_ICD_9	0785X
COD_ICD_8	0795
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other/unspecified cytomegaloviral diseases based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	3534	1602	1906
Only index persons	2987	1369	1618
Unadjusted period prevalence (%)
Whole population	0.05	0.05	0.05
Only index persons	0.06	0.05	0.06
Median age at first event (years)
Whole population	51.68	52.05	51.36
Only index persons	52.44	52.68	52.24

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	698	342	356
Unadjusted period prevalence (%)	0.14	0.12	0.16
Median age at first event (years)	55.49	54.24	56.69

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
750: Matched controls
7500

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

195.1

317.9

155

L04AD02

ATC

tacrolimus; systemic

111.3

307.7

237

TK800

NOMESCO Finland

Hemodialysis

57.6

307.7

218

L04AD01

ATC

ciclosporin; systemic

54.6

307.7

221

127

Kela drug reimbursment

Transplant complication

196.1

307.7

398

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

176.9

307.7

215

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

24.1

307.7

285

186

A11CC03

ATC

alfacalcidol; systemic

50.8

307.7

210

L04AA06

ATC

mycophenolic acid; systemic

120.4

307.7

353

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

63.3

307.7

233

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

+∞

307.7

424

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

25.2

307.7

336

234

Z94.0

ICD-10 Finland

Kidney transplant status

165.5

307.7

253

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

73.5

307.7

234

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

+∞

307.7

368

B03XA02

ATC

darbepoetin alfa; parenteral

48.4

305.8

184

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

170.2

304.4

150

H02AB04

ATC

methylprednisolone; systemic

13.8

299.1

405

587

Z49.1

ICD-10 Finland

Extracorporeal dialysis

73.9

289.2

158

A12AA04

ATC

calcium carbonate; oral

54.5

268.6

156

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

91.2

256.1

135

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

11.3

246.6

369

591

137

Kela drug reimbursment

Uraemia requiring dialysis

84.7

238.5

127

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

88.9

238.3

126

N18.8

ICD-10 Finland

Other chronic renal failure

42.3

238.0

147

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

18.7

237.5

210

153

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

19.1

235.4

205

145

R50.9

ICD-10 Finland

Fever, unspecified

10.0

225.3

386

717

XW000

NOMESCO Finland

Bone marrow biopsy

19.0

216.8

187

129

A49.9

ICD-10 Finland

Bacterial infection, unspecified

10.9

214.4

299

431

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

24.3

201.2

151

V03AE01

ATC

polystyrene sulfonate; oral

62.5

200.0

112

B05DA

ATC

Isotonic solutions

77.0

196.4

106

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

47.8

192.1

114

N18.0

ICD-10 Finland

End-stage renal disease

63.4

186.4

104

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

76.8

185.3

100

C03CA01

ATC

furosemide; systemic

8.0

184.8

438

1114

L04AA01

ATC

[U] ciclosporin

51.8

183.9

107

Z49.2

ICD-10 Finland

Other dialysis

74.1

178.8

B05DB

ATC

Hypertonic solutions

77.6

176.3

Z49.0

ICD-10 Finland

Preparatory care for dialysis

52.3

172.4

100

A05AA02

ATC

ursodeoxycholic acid; oral

31.4

171.6

115

TPX10

NOMESCO Finland

Implantation of vascular injection port

18.5

164.0

139

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

34.7

162.3

105

WW500

NOMESCO Finland

Blood transfusion

14.8

157.5

153

128

ZX120

NOMESCO Finland

Intravenous

8.5

147.3

233

377

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

6.8

143.2

321

744

L03AA02

ATC

filgrastim; parenteral

15.5

142.8

133

103

M04AA01

ATC

allopurinol; systemic

7.8

142.2

251

457

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

9.9

141.1

187

244

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

65.9

139.3

KBV00

NOMESCO Finland

Insertion of stent into ureter

55.1

138.1

L04AX01

ATC

azathioprine; systemic

13.0

137.3

143

133

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

49.6

136.7

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

73.4

134.4

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

6.0

132.1

449

1495

WW200

NOMESCO Finland

Immunization

16.4

128.1

114

ZX108

NOMESCO Finland

Inhalation

40.3

118.7

GD1AA

NOMESCO Finland

Thorax X-ray examination

6.8

118.2

590

2643

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

58.2

113.2

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

10.5

110.5

133

151

N17.9

ICD-10 Finland

Acute renal failure, unspecified

11.9

109.4

119

117

H05BX01

ATC

cinacalcet; oral

52.8

109.3

B03XA01

ATC

erythropoietin; parenteral

41.8

106.8

R4110

NOMESCO Finland

Physiotherapy

4.9

104.1

401

1416

J18.9

ICD-10 Finland

Pneumonia, unspecified

4.9

102.0

356

1160

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

43.4

99.5

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

6.5

99.1

193

378

A41.9

ICD-10 Finland

Sepsis, unspecified

11.4

94.1

104

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

49.4

94.1

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

8.7

94.1

131

178

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

11.0

93.8

107

112

TK820

NOMESCO Finland

Peritoneal dialysis

57.0

93.4

H02AB09

ATC

hydrocortisone; systemic

14.1

93.0

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

139.0

92.4

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

11.9

92.1

KA1AE

NOMESCO Finland

Kidney ultrasound examination

14.1

91.2

JN4AD

NOMESCO Finland

Body CT examination

5.5

88.1

211

497

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

28.3

87.7

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

42.9

86.1

TPH04

NOMESCO Finland

Cathetrisation of vein

4.5

85.6

318

1063

J01MA12

ATC

levofloxacin; systemic

4.7

84.1

265

780

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

8.1

81.5

119

170

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

7.2

80.9

133

217

TGC00

NOMESCO Finland

Bronchial lavation

10.8

80.6

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

5.7

80.1

178

390

Z2446

NOMESCO Finland

Social worker

6.5

79.4

146

267

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

13.5

79.0

321

Kela drug reimbursment

Paricalcitol and cinacalcet

37.4

78.3

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

19.0

78.3

V03AE02

ATC

sevelamer; oral

116.5

77.7

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

20.3

76.9

ZXE20

NOMESCO Finland

More than three and less than five hours

4.8

74.2

210

562

A10AC01

ATC

insulin (human); parenteral

6.1

74.0

147

289

GD1AD

NOMESCO Finland

Thorax CT examination

6.5

73.5

135

246

205

Kela drug reimbursment

Chronic hypertension

4.0

71.8

292

1022

WX408

NOMESCO Finland

General anesthesy, balanced

3.9

71.2

333

1281

H3603, E103,

ICD-10 Finland

32.6

70.6

196

Kela drug reimbursment

Paricalcitol and cinacalcet

93.9

69.4

C02AC05

ATC

moxonidine; oral

8.4

69.4

131

C08CA01

ATC

amlodipine; oral

3.7

69.1

413

1858

J05AB11

ATC

valaciclovir; oral

4.4

68.9

227

680

TPH07

NOMESCO Finland

Cathetrisation of artery

4.9

68.6

180

451

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

7.3

66.4

105

163

A07AA09

ATC

vancomycin; oral

18.1

65.8

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.7

65.7

341

1391

JN3AD

NOMESCO Finland

Abdominal CT examination

4.4

65.6

207

598

ZXD05

NOMESCO Finland

Urgent procedure

3.6

65.1

355

1492

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

3.7

65.1

308

1181

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.2

64.0

220

676

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

16.4

63.7

D70.89

ICD-10 Finland

Neutropenic splenomegaly

17.9

63.1

A10AB05

ATC

insulin aspart; parenteral

5.4

62.0

139

303

UGC12

NOMESCO Finland

Flexible bronchoscopy

5.6

61.5

132

277

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

3.9

61.0

238

797

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

12.7

60.8

B99

ICD-10 Finland

Other and unspecified infectious diseases

13.0

60.6

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

3.8

60.3

255

901

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

4.5

60.0

173

464

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

26.1

59.9

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

26.1

59.9

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

10.6

59.8

KBV10

NOMESCO Finland

Removal of stent from ureter

22.2

58.9

WX892

NOMESCO Finland

Monitored bed care

5.3

58.3

133

294

R4190

NOMESCO Finland

Nutritional therapy

6.7

57.7

167

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

11.0

56.2

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

16.5

55.9

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

205.3

55.8

C90.0

ICD-10 Finland

Multiple myeloma

19.4

55.6

RS220, ,

NOMESCO Finland

14.9

54.1

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

9.1

53.9

J01MA14

ATC

moxifloxacin; systemic

4.7

53.5

140

346

C07AG02

ATC

carvedilol; oral

5.9

53.0

103

196

N17.8

ICD-10 Finland

Other acute renal failure

18.2

52.7

K65.0

ICD-10 Finland

Acute peritonitis

21.1

52.4

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

23.5

52.1

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

69.7

51.0

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

4.3

51.0

153

420

D70.82

ICD-10 Finland

Drug-induced neutropenia

10.4

48.9

C08CA02

ATC

felodipine; oral

4.8

48.6

124

299

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

3.0

48.4

438

2370

D64.9

ICD-10 Finland

Anaemia, unspecified

4.4

48.0

137

361

ZXE30

NOMESCO Finland

More than five and less than seven hours

6.0

47.4

167

J01MA02

ATC

ciprofloxacin; systemic

3.0

47.4

383

1941

A10AB01

ATC

insulin (human); parenteral

7.1

47.2

116

A07AA02

ATC

nystatin; oral

6.0

47.1

168

JN4BD

NOMESCO Finland

Extensive body CT

4.2

47.1

146

409

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

4.0

46.8

159

476

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

6.7

46.4

128

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

4.7

46.1

118

285

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

4.4

45.8

131

345

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

7.6

45.2

WX402

NOMESCO Finland

General anaesthesia

3.1

44.3

270

1162

WX002

NOMESCO Finland

Sedation and analgesia

3.3

43.7

214

810

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

7.1

43.2

104

H43.1

ICD-10 Finland

Vitreous haemorrhage

8.4

43.1

B01AB10

ATC

tinzaparin; parenteral

3.8

42.5

153

475

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

12.3

42.4

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

6.0

42.0

145

Z94.4

ICD-10 Finland

Liver transplant status

58.1

42.0

WZC00

NOMESCO Finland

Treatment plan or consultation

2.8

42.0

383

2034

UJF32

NOMESCO Finland

Coloscopy

3.0

42.0

272

1206

ZXE00

NOMESCO Finland

One hour or less

2.8

41.6

376

1985

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

9.4

41.5

H02AB06

ATC

prednisolone; systemic

2.8

41.2

450

2612

U14

ICPC

Kidney symptom/complaint

12.0

40.8

N02AA05

ATC

oxycodone; systemic

3.3

40.7

199

749

WX872

NOMESCO Finland

Intensive care

5.3

40.4

181

C02CA01

ATC

prazosin; oral

16.9

40.3

ZXE10

NOMESCO Finland

More than one and less than three hours

2.8

40.0

350

1807

N02AX02

ATC

tramadol; systemic, rectal

2.7

40.0

417

2352

Z3226

NOMESCO Finland

Physiotherapist

3.2

39.6

207

809

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

16.1

39.3

C09AA02

ATC

enalapril; systemic

3.2

39.3

198

757

5AB14, ,

NOMESCO Finland

144.3

39.1

A04AA01

ATC

ondansetron; systemic, rectal

4.2

39.0

117

318

A41.8

ICD-10 Finland

Other specified sepsis

9.4

38.4

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

8.1

38.2

212

Kela drug reimbursment

Gout

11.1

37.8

V03AE03

ATC

lanthanum carbonate; oral

58.3

37.8

SPAT1255

SPAT

Intravenous administration of medicine

4.8

37.1

211

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

8.5

37.1

WX882

NOMESCO Finland

High dependency care

7.3

36.9

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

7.3

36.9

ZXA00

NOMESCO Finland

Right side

2.8

36.8

265

1228

C07AB02

ATC

metoprolol; systemic

3.1

36.8

190

735

J05AB01

ATC

aciclovir; systemic

2.9

36.6

234

1018

WW302

NOMESCO Finland

Allogenic transfer of stem cells from relative

374.5

36.3

Z3231

NOMESCO Finland

Registered nurse

2.7

36.2

281

1352

J01FF01

ATC

clindamycin; systemic

2.7

35.8

280

1350

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

5.2

35.2

162

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

41.4

34.7

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

4.9

34.4

177

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

8.4

34.4

A02BC02

ATC

pantoprazole; systemic

3.0

34.3

588

4119

A10AA01, ,

ATC

6.7

33.4

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

6.1

33.4

105

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

4.6

33.3

203

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

11.4

33.1

JN6AD

NOMESCO Finland

CT of torso and neck

8.2

33.1

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

5.4

33.1

139

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

7.8

33.0

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

4.2

32.9

245

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

11.8

32.9

A02BC01

ATC

omeprazole; systemic

2.6

32.8

258

1239

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

9.1

32.2

A10AB04

ATC

insulin lispro; parenteral

5.8

31.8

110

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

8.0

31.7

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.9

31.2

174

697

AA1AD

NOMESCO Finland

CT of head and brain

2.5

31.0

273

1377

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

89.0

31.0

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

6.5

30.9

RD210, ,

NOMESCO Finland

8.3

30.5

121

Kela drug reimbursment

Severe hypofunction of sexual glands

7.6

30.4

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

5.3

30.3

130

WZC30

NOMESCO Finland

Teaching

2.8

30.1

188

798

A10AA02, ,

ATC

5.9

29.7

JJC00

NOMESCO Finland

Allogenic transplantation of liver

59.2

29.4

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.7

29.3

101

301

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

68.9

29.1

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

68.9

29.1

K51.5

ICD-10 Finland

Left sided colitis

5.9

28.9

C08CA05

ATC

nifedipine; systemic

4.6

28.8

173

C07AB07

ATC

bisoprolol; oral

2.3

28.7

401

2465

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

5.7

28.5

103

H26.3

ICD-10 Finland

Drug-induced cataract

28.5

28.2

E87.5

ICD-10 Finland

Hyperkalaemia

8.4

28.0

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.3

27.8

119

407

B34.9

ICD-10 Finland

Viral infection, unspecified

5.5

27.6

106

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

3.5

27.5

104

329

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

55.6

27.4

TK810

NOMESCO Finland

Hemofiltration

33.3

27.1

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

43.1

27.0

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

2.5

26.9

236

1176

B01AB04

ATC

dalteparin; parenteral

4.8

26.9

140

B02.9

ICD-10 Finland

Zoster without complication

3.8

26.8

258

N19

ICD-10 Finland

Unspecified kidney failure

5.4

26.5

106

A10AE04

ATC

insulin glargine; parenteral

3.2

26.5

117

407

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

53.8

26.4

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

5.8

26.3

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

9.8

26.3

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

4.3

26.3

181

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

7.1

26.1

H26.2

ICD-10 Finland

Complicated cataract

10.0

26.0

M10.9

ICD-10 Finland

Gout, unspecified

3.8

25.8

240

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

4.8

25.7

133

R11

ICD-10 Finland

Nausea and vomiting

3.3

25.5

107

361

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

9.7

25.4

UJF30

NOMESCO Finland

Ileoscopy through colon

3.1

25.4

121

440

L03AA13

ATC

pegfilgrastim; parenteral

4.3

25.2

169

Z01.8

ICD-10 Finland

Other specified special examinations

2.4

25.0

223

1115

T86.1

ICD-10 Finland

Kidney transplant failure and rejection

72.5

25.0

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

93.3

24.8

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

134.5

24.7

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

5.8

24.2

B01AB05

ATC

enoxaparin; parenteral

2.3

24.1

271

1492

ZXA05

NOMESCO Finland

Left side

2.4

24.1

217

1086

EP1AE

NOMESCO Finland

Neck ultrasound examination

3.8

24.0

222

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

9.4

24.0

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

7.0

24.0

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.5

23.9

189

891

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

7.7

23.9

WX720

NOMESCO Finland

Own respiration

4.0

23.9

190

N08.2*D89.80

ICD-10 Finland

Immunoglobulin A (IgA) nephropathy

27.8

23.7

WW306

NOMESCO Finland

Transfer of stem cells from foreign registered donator

129.1

23.7

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.2

23.7

460

3141

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

4.4

23.6

151

ZX112

NOMESCO Finland

Subcutaneous

6.3

23.5

C08CA13

ATC

lercanidipine; oral

2.7

23.5

145

606

A10AE05

ATC

insulin detemir; parenteral

3.9

23.5

197

3AC01, ,

NOMESCO Finland

25.6

23.2

NHQ40

NOMESCO Finland

Amputation of toe

8.2

23.2

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

8.2

23.2

A06AD11

ATC

lactulose; oral

2.8

23.1

131

523

ZXE40

NOMESCO Finland

More than seven and less than nine hours

5.9

22.8

Z2221

NOMESCO Finland

Medical doctor

2.3

22.8

246

1327

H05BX02

ATC

paricalcitol; systemic

236.9

22.7

N05CF01

ATC

zopiclone; oral

2.2

22.6

276

1564

TAB00

NOMESCO Finland

Lumbar puncture

4.1

22.5

170

WX203

NOMESCO Finland

Infraclavicular plexus blockade

6.1

22.5

Z3229

NOMESCO Finland

Other healthcare associate professional

3.3

22.2

312

M05BA04

ATC

alendronic acid; oral

3.6

22.2

234

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.4

22.2

200

997

K83.0

ICD-10 Finland

Cholangitis

9.3

22.2

TPX15

NOMESCO Finland

Removal of vascular injection port

36.3

22.2

SAA04

NOMESCO Finland

Special examination of mouth

3.7

22.0

211

A03

ICPC

Fever

2.4

22.0

185

895

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

23.0

21.8

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.7

21.7

139

590

A12AA12

ATC

[U] calcium acetate

226.3

21.7

SAA03

NOMESCO Finland

Extended examination of mouth

2.1

21.6

361

2299

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

5.4

21.5

A46

ICD-10 Finland

Erysipelas

2.6

21.5

144

625

M01AE01

ATC

ibuprofen; systemic, rectal

0.4

21.5

513

6215

A03FA01

ATC

metoclopramide; systemic, rectal

2.3

21.3

202

1027

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

4.1

21.3

163

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

3.0

21.1

104

384

Q61.3

ICD-10 Finland

Polycystic kidney, unspecified

29.0

21.1

WW300

NOMESCO Finland

Transfer of autologic stem cells

29.0

21.1

JAL10

NOMESCO Finland

Laparotomy and removal of foreign body

61.9

21.0

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

3.8

20.9

184

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.2

20.9

313

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

3.6

20.8

224

J02AC03

ATC

voriconazole; systemic

31.0

20.7

I50.9

ICD-10 Finland

Heart failure, unspecified

2.9

20.5

109

419

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.0

20.5

100

367

PJA10

NOMESCO Finland

Exploration of lymph nodes

7.7

20.5

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

3.4

20.4

242

SPAT1262

SPAT

Handing over of treatment supplies

2.4

20.3

161

755

Y84.8

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

17.9

20.2

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

59.2

20.0

B01AA03

ATC

warfarin; systemic

2.5

19.8

139

615

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

4.3

19.8

131

A07EC02

ATC

mesalazine; oral, rectal

3.6

19.6

207

A07EA06

ATC

budesonide; oral, local oral

4.2

19.6

132

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

15.1

19.5

WX704

NOMESCO Finland

Intubation

3.0

19.2

339

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

4.1

19.2

143

ZXD10

NOMESCO Finland

Scheduled procedure

2.0

19.0

304

1882

Z94.2

ICD-10 Finland

Lung transplant status

56.6

19.0

E86

ICD-10 Finland

Volume depletion

6.0

19.0

WW409

NOMESCO Finland

Other aferesis

28.7

18.8

WX202

NOMESCO Finland

Supraclavicular plexus blockade

7.0

18.8

WW400

NOMESCO Finland

Plasmaferesis

71.8

18.8

Z94.1

ICD-10 Finland

Heart transplant status

24.4

18.7

NEA10

NOMESCO Finland

Exploration of soft tissue of pelvis, percutaneous

21.5

18.7

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

5.6

18.7

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

3.3

18.6

240

JLE03

NOMESCO Finland

Allogenic total transplantation of pancreas with pancreaticoenterostomy

194.7

18.6

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

3.4

18.5

220

XCK10

NOMESCO Finland

Photography of fundus of eye

2.9

18.5

358

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

2.2

18.5

187

971

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

30.9

18.4

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

4.9

18.4

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

8.0

18.4

B07.9

ICD-10 Finland

Verruca simplex

4.2

18.2

126

ZXA10

NOMESCO Finland

Bilateral

2.3

18.1

157

763

6BA02, ,

NOMESCO Finland

53.9

18.0

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

53.9

18.0

ED1AA

NOMESCO Finland

Mandibular X-ray examination

17.1

18.0

J01DB01

ATC

cefalexin; oral

2.6

17.9

651

5382

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

7.1

17.9

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

18.6

17.9

WVA20

NOMESCO Finland

Medicine administration

4.5

17.8

102

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

15.0

17.7

C09CA01

ATC

losartan; oral

2.1

17.6

219

1231

Z51.5

ICD-10 Finland

Palliative care

3.1

17.5

282

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

24.7

17.4

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

4.8

17.2

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

5.4

17.2

T89

ICPC

Diabetes insulin dependent

3.6

17.1

170

N03.8

ICD-10 Finland

Chronic nephritic syndrome, other

51.3

17.1

KAS20

NOMESCO Finland

Allogenic transplantation of kidney from living donor

51.3

17.1

C02EA02, ,

ATC

4.7

17.0

153

Kela drug reimbursment

Lenalidomid

22.5

16.9

H02AB02

ATC

dexamethasone; systemic

2.5

16.9

114

494

G04CA02

ATC

tamsulosin; oral

2.1

16.8

193

1049

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

64.9

16.8

WX100

NOMESCO Finland

Conjunctival surface anesthesia

2.6

16.7

105

439

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

4.2

16.7

116

ZX197, ,

NOMESCO Finland

92.2

16.6

H36.00

ICD-10 Finland

Diabetic background retinopathy

7.1

16.6

S97

ICPC

Chronic ulcer skin

3.1

16.6

246

C10AA03

ATC

pravastatin; oral

3.1

16.5

242

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

5.9

16.4

XG410

NOMESCO Finland

Flow-volume spirometry

3.9

16.4

131

WX204

NOMESCO Finland

Axillary plexus blockaced

3.9

16.4

136

WX110

NOMESCO Finland

Infiltration anesthesia

2.1

16.3

578

4610

C08CA10

ATC

nilvadipine; oral

6.7

16.3

CKC12

NOMESCO Finland

Photocoagulation of retina

3.8

16.3

146

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

3.1

16.1

245

3025

Kela drug reimbursment

Calcium carbonate

19.0

16.1

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

48.6

16.1

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

25.1

16.1

L04AX04

ATC

lenalidomide; oral

21.5

16.1

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.3

16.0

203

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

4.5

15.9

TK824

NOMESCO Finland

Replacement of peritoneal dialysis catheter extension tube

61.4

15.8

PBU84

NOMESCO Finland

Plastic repair of arteriovenous fistula from artery of upper extremity

61.4

15.8

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

34.2

15.8

H36.01

ICD-10 Finland

Diabetic maculopathy

7.1

15.8

XF400

NOMESCO Finland

ECG with 12 standard connections

2.3

15.7

137

665

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.6

15.7

396

M01AH05

ATC

etoricoxib; oral

0.5

15.6

274

3924

JJ5AT, ,

NOMESCO Finland

86.9

15.6

N04.1

ICD-10 Finland

Nephrotic syndrome, focal and segmental glomerular lesions

86.9

15.6

5BA08, ,

NOMESCO Finland

22.6

15.6

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

22.6

15.6

GD1LA

NOMESCO Finland

6.4

15.6

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.8

15.5

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

4.3

15.5

100

N03.1

ICD-10 Finland

Chronic nephritic syndrome, focal and segmental glomerular lesions

163.3

15.5

Z96.1

ICD-10 Finland

Presence of intraocular lens

2.5

15.3

110

489

ZX100

NOMESCO Finland

Oral

7.2

15.3

329

Kela drug reimbursment

Lenalidomide

29.3

15.2

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.4

15.2

111

498

B59

ICD-10 Finland

Pneumocystosis

46.0

15.1

Z99.2

ICD-10 Finland

Dependence on renal dialysis

46.0

15.1

TQW11

NOMESCO Finland

Vacuum treatment of wound

5.1

15.1

XPX08

NOMESCO Finland

Intraoperative flow measurement

14.3

15.1

TDM10

NOMESCO Finland

Puncture of maxillary antrum

3.6

15.1

144

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

4.3

15.1

WX199

NOMESCO Finland

Other local analgesia

4.3

15.1

M05BX04

ATC

denosumab; parenteral

3.4

15.1

174

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

3.2

15.1

200

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

5.9

15.0

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

3.3

15.0

180

N03AX16

ATC

[U] pregabalin

2.0

14.9

194

1099

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

11.6

14.9

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

5.0

14.9

K65.9

ICD-10 Finland

Peritonitis, unspecified

57.9

14.8

WX725

NOMESCO Finland

Noninvasive ventilation

3.1

14.8

213

EBA10

NOMESCO Finland

Operative extraction of tooth

2.3

14.8

126

605

CKD91

NOMESCO Finland

Extended vitrectomy through pars plana

6.3

14.7

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.6

14.7

383

TQW99

NOMESCO Finland

Other minor procedure on skin

3.3

14.7

177

R31

ICD-10 Finland

Unspecified haematuria

2.6

14.7

396

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

6.5

14.6

187

Kela drug reimbursment

MPA

+∞

14.6

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.7

14.6

329

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

5.6

14.6

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

6.7

14.5

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

3.3

14.5

178

RJ410, ,

NOMESCO Finland

36.8

14.5

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

14.5

294

1930

C82.1

ICD-10 Finland

Follicular lymphoma grade II

17.4

14.4

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.1

14.3

156

826

E83.50

ICD-10 Finland

Hypercalcemia

10.7

14.3

WX302

NOMESCO Finland

Thoracal epidural anesthesy

3.3

14.3

175

A04AA02

ATC

granisetron; systemic, transdermal

2.9

14.2

252

L04AA05

ATC

[U] tacrolimus

43.4

14.2

K65.8

ICD-10 Finland

Other peritonitis

43.4

14.2

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

3.7

14.1

131

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

6.8

14.1

XF600

NOMESCO Finland

Bloodpressure measurement

3.0

14.0

231

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

13.0

14.0

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

11.7

13.9

GDG10

NOMESCO Finland

Bilateral transplantation of lung

54.4

13.9

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

54.4

13.9

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

10.7

13.8

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

5.5

13.8

J02AC01

ATC

fluconazole; systemic

1.8

13.7

287

1894

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.9

13.7

245

TKC20

NOMESCO Finland

Catheterisation of bladder

3.0

13.6

229

YNB10

NOMESCO Finland

Collection of stem cells for transplant

76.6

13.6

PG5AC

NOMESCO Finland

Contrast examination of injection gate to artery or vein

+∞

13.6

JL9AE

NOMESCO Finland

Ultrasound examination of pancreas transplant

+∞

13.6

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.3

13.6

1224

Y83.0

ICD-10 Finland

Surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

34.7

13.5

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

5.3

13.5

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

16.6

13.5

J05AX18

ATC

letermovir; oral

142.5

13.5

N03.3

ICD-10 Finland

Chronic nephritic syndrome, diffuse mesangial proliferative glomerulonephritis

142.5

13.5

GD2SN

NOMESCO Finland

Lung ventilation SPECT

18.6

13.4

M10.3

ICD-10 Finland

Gout due to impairment of renal function

26.3

13.4

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.5

13.3

382

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

5.5

13.3

103

Kela drug reimbursment

Diabetes, insulin-treated

1.9

13.2

212

1283

9861/3-C42.1

ICD-O-3

Acute myeloid leukemia, NOS, of bone marrow

40.9

13.2

RJ411, ,

NOMESCO Finland

15.4

13.2

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

15.4

13.2

A28

ICPC

Limited function/disability NOS

2.2

13.1

125

626

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

10.3

13.1

E21.2

ICD-10 Finland

Other hyperparathyroidism

28.9

13.0

UKC02

NOMESCO Finland

Cystoscopy

2.2

13.0

128

650

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.1

13.0

191

UJF92

NOMESCO Finland

Capsular endoscopy

4.7

12.9

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

3.8

12.9

110

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.8

12.9

110

N04.9

ICD-10 Finland

Nephrotic syndrome, unspecified

50.9

12.9

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

11.8

12.9

WX140

NOMESCO Finland

Parabulbar anesthesy

3.3

12.8

160

WX610

NOMESCO Finland

Patient controlled analgesia

14.4

12.8

CJB10

NOMESCO Finland

Laser discission of secondary cataract

2.8

12.7

238

D64.8

ICD-10 Finland

Other specified anaemias

6.1

12.7

C92.1

ICD-10 Finland

Chronic myeloid leukaemia [CML], BCR/ABL-positive

32.6

12.6

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

17.7

12.6

WW304

NOMESCO Finland

Transfer of stem cells from registered domestic donator

+∞

12.5

5AD01, ,

NOMESCO Finland

+∞

12.5

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

6.3

12.5

J01CA04

ATC

amoxicillin; systemic

2.1

12.5

631

5372

I50.1

ICD-10 Finland

Left ventricular failure

3.5

12.5

132

K06.18

ICD-10 Finland

Another gingival hyperplasia

20.4

12.5

D89.80

ICD-10 Finland

Immunoglobulin A (IgA) deposits in organisms

132.1

12.5

H02AB07

ATC

prednisone; oral

2.2

12.5

109

527

C03AA03

ATC

hydrochlorothiazide; oral

2.7

12.5

264

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.9

12.4

H3601, E103,

ICD-10 Finland

11.9

12.4

HA1AA

NOMESCO Finland

X-ray mammography

2.6

12.4

301

I50.0

ICD-10 Finland

Congestive heart failure

3.0

12.3

191

PB1DE

NOMESCO Finland

Upper extremity arteries ultrasound examination with Doppler method

14.6

12.3

J12.8

ICD-10 Finland

Other viral pneumonia

10.7

12.3

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.4

12.3

396

JN4CD

NOMESCO Finland

Very extensive body CT

3.7

12.3

109

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

3.1

12.3

175

R4180

NOMESCO Finland

Podiatric therapy

5.6

12.2

ZY010

NOMESCO Finland

Hospital outpatient

2.9

12.2

215

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.1

12.1

171

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

4.0

12.1

A12BA01

ATC

potassium chloride; oral

4.0

12.1

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

13.7

12.0

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

5.0

12.0

N25.0

ICD-10 Finland

Renal osteodystrophy

47.5

11.9

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

3.0

11.9

195

L01BB02

ATC

mercaptopurine; oral

6.0

11.8

K50.8

ICD-10 Finland

Other Crohn disease

4.9

11.7

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.8

11.7

231

1XC02, ,

NOMESCO Finland

16.7

11.7

ZX121

NOMESCO Finland

Central venous catheter

16.7

11.7

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.9

11.7

199

1222

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.9

11.7

166

961

B01AF02

ATC

apixaban; oral

2.3

11.7

100

479

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

3.4

11.7

133

N30.0

ICD-10 Finland

Acute cystitis

2.1

11.6

122

634

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

5.4

11.6

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

5.4

11.6

201

Kela drug reimbursment

Chronic cardiac insufficiency

3.1

11.6

165

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

10.3

11.6

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

5.8

11.5

J17.1*B25.0

ICD-10 Finland

Cytomegaloviral pneumonitis

+∞

11.5

0785X

ICD-9 Finland

Other diseases due to viruses and Chlamydiae, Cytomegaloviral disease[VIROSIS ALIA CYTOMEGALICA]

+∞

11.5

KAS40

NOMESCO Finland

Excision of transplanted kidney

+∞

11.5

58209

ICD-8 Finland

Chronic nephritis, Unspecified

121.8

11.5

7151

FHL

Kidney transplantation

121.8

11.5

RJ420, ,

NOMESCO Finland

15.3

11.3

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

9.1

11.3

N08.2

ICD-10 Finland

Glomerular disorders in blood diseases and disorders involving the immune mechanism

35.6

11.3

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

35.6

11.3

R18

ICD-10 Finland

Ascites

4.8

11.3

XQ848

NOMESCO Finland

Dermatological photography

3.8

11.2

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

5.7

11.2

RJ421, ,

NOMESCO Finland

25.5

11.2

I15.0

ICD-10 Finland

Renovascular hypertension

20.4

11.2

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

20.4

11.2

H25.1

ICD-10 Finland

Senile nuclear cataract

1.9

11.1

165

968

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

11.4

11.1

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

8.8

11.1

XX1XW

NOMESCO Finland

Extensive written report from radiologist

4.5

11.1

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

5.1

11.1

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

4.9

11.0

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

14.2

11.0

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

2.4

10.9

364

XF612

NOMESCO Finland

Measurement of central venous pressure

44.0

10.9

J02AC04

ATC

posaconazole; systemic

44.0

10.9

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.6

10.9

264

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.8

10.9

225

1461

GD1UN

NOMESCO Finland

Lung circulation SPECT

21.8

10.7

KAC00

NOMESCO Finland

Nephrectomy

21.8

10.7

EBA15

NOMESCO Finland

Extraction of multiple teeth

3.1

10.7

151

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

8.1

10.7

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

8.1

10.7

PB1AC

NOMESCO Finland

Angiography of upper extremity with X-ray

60.9

10.6

2503B

ICD-9 Finland

Diabetes mellitus, Diabetes with other coma[SOKERITAUDIN AIHEUTTAMA MUNUAISSAIRAUS,TYYPPI I]

60.9

10.6

C95.0

ICD-10 Finland

Acute leukaemia of unspecified cell type

60.9

10.6

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

11.4

10.6

SBA00

NOMESCO Finland

Microbiological examinations

4.1

10.6

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.7

10.5

221

XX3ZW, ,

NOMESCO Finland

111.5

10.4

ZX196, ,

NOMESCO Finland

111.5

10.4

N0832, E102,

ICD-10 Finland

+∞

10.4

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

10.4

294

2075

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.9

10.4

149

863

XX4BW, ,

NOMESCO Finland

33.0

10.4

2507B

ICD-9 Finland

Diabetes mellitus, Diabetes with peripheral circulatory disorders[DIABETES MELLITUS CUM COMPLICAT ALIA ,TYYPPI I]

33.0

10.4

1CX01, ,

NOMESCO Finland

33.0

10.4

L04AA10

ATC

[U] sirolimus

33.0

10.4

C08DB01

ATC

diltiazem; oral

3.3

10.3

118

JMA10

NOMESCO Finland

Transabdominal total splenectomy

13.3

10.2

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

13.3

10.2

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

13.3

10.2

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

3.4

10.1

109

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

8.6

10.1

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

3.8

10.1

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

4.9

10.1

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

4.9

10.1

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.2

10.0

467

7531A

ICD-9 Finland

Congenital anomalies of urinary system, Cystic kidney disease

40.6

10.0

H3603, E107,

ICD-10 Finland

40.6

10.0

N11.9

ICD-10 Finland

Chronic tubulo-interstitial nephritis, unspecified

40.6

10.0

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

12.4

9.9

K51.8

ICD-10 Finland

Other ulcerative colitis

4.5

9.9

XQ845

NOMESCO Finland

Dermatoscopy

4.5

9.9

J20.6

ICD-10 Finland

Acute bronchitis due to rhinovirus

26.4

9.8

RS221, ,

NOMESCO Finland

5.0

9.8

A10AD01

ATC

insulin (human); parenteral

5.0

9.8

TPH00

NOMESCO Finland

Phlebotomy

20.3

9.8

H26.4

ICD-10 Finland

After-cataract

2.4

9.8

310

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.9

9.8

145

848

EB1AI

NOMESCO Finland

Cone beam imaging of teeth and jaws (one quarter)

4.3

9.7

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

8.0

9.7

XF402

NOMESCO Finland

ECG with work load test

2.2

9.6

398

204

Kela drug reimbursment

Leukemia lymphatica

3.7

9.6

TQW80

NOMESCO Finland

Local dermatologic skincare

3.9

9.6

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

7.3

9.6

E000001, ,

ATC

1.9

9.5

148

877

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

15.3

9.5

V03AE04

ATC

calcium acetate and magnesium carbonate; systemic

101.3

9.4

N28.9

ICD-10 Finland

Disorder of kidney and ureter, unspecified

17.8

9.4

XW4XT

NOMESCO Finland

Biopsy of other inner organ with radiological guidance guidance

17.8

9.4

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

17.8

9.4

E21.1

ICD-10 Finland

Secondary hyperparathyroidism, not elsewhere classified

30.4

9.4

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

30.4

9.4

N11.8

ICD-10 Finland

Other chronic tubulo-interstitial nephritis

+∞

9.4

07959

ICD-8 Finland

Other viral diseases, Virosis cytomegalica NUD

+∞

9.4

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

7.1

9.4

CKC10

NOMESCO Finland

Local photocoagulation of retina

4.8

9.3

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

4.8

9.3

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

9.3

154

930

SPAT1263

SPAT

Sampling

1.6

9.3

300

2177

L28

ICPC

Limited function/disability (L)

1.9

9.2

129

740

I10

ICD-10 Finland

Essential (primary) hypertension

1.6

9.2

427

3381

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

9.1

197

1285

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

15.8

9.1

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

15.8

9.1

H3603, E113,

ICD-10 Finland

10.2

9.1

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

4.2

9.0

RJ120, ,

NOMESCO Finland

37.2

9.0

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

37.2

9.0

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

3.5

9.0

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

7.6

9.0

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

7.6

9.0

D63.8

ICD-10 Finland

Anaemia in other chronic diseases classified elsewhere

18.9

9.0

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.9

8.9

145

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

24.3

8.9

C10AA01

ATC

simvastatin; oral

1.6

8.9

269

1914

ZX090

NOMESCO Finland

Other technic of radiotherapy

3.7

8.9

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

8.1

8.9

XQ902

NOMESCO Finland

Other photography

8.1

8.9

D59.1

ICD-10 Finland

Other autoimmune haemolytic anaemias

12.7

8.9

M05BA07

ATC

risedronic acid; oral

4.6

8.9

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

5.0

8.9

B01AC04

ATC

clopidogrel; oral

1.9

8.9

117

657

J96.1

ICD-10 Finland

Chronic respiratory failure

4.8

8.9

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

2.1

8.8

454

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

9.6

8.8

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

7.3

8.8

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

7.3

8.8

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.9

8.8

141

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

8.7

293

2137

E0000UV, ,

ATC

1.6

8.7

304

2238

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

3.0

8.7

136

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

14.2

8.7

JAH00

NOMESCO Finland

Laparotomy

3.3

8.7

V03AG01

ATC

sodium cellulose phosphate; systemic

50.6

8.7

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

7.8

8.7

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.1

8.7

115

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

7.1

8.6

L01AA01

ATC

cyclophosphamide; systemic

16.5

8.6

R04.0

ICD-10 Finland

Epistaxis

2.4

8.6

276

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.3

8.6

302

CKC15

NOMESCO Finland

Panretinal photocoagulation

10.2

8.6

NGQ20

NOMESCO Finland

Amputation of lower leg

10.2

8.6

PG1AE

NOMESCO Finland

Ultrasound examination of artery not elsewher classified

10.2

8.6

J96.0

ICD-10 Finland

Acute respiratory failure

6.5

8.5

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

3.0

8.5

127

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

20.3

8.5

120

Kela drug reimbursment

Hypogammaglobulinaemia

20.3

8.5

D07AB08

ATC

desonide; topical

2.1

8.5

461

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

3.2

8.5

106

H30.1

ICD-10 Finland

Disseminated chorioretinal inflammation

91.0

8.4

L04AH02

ATC

everolimus; oral

91.0

8.4

N0830, E102,

ICD-10 Finland

91.0

8.4

C10AA05

ATC

atorvastatin; oral

1.6

8.4

299

2206

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.4

8.4

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

8.0

8.4

5901A

ICD-9 Finland

Infections of kidney, Acute pyelonephritis

12.9

8.4

B25.0

ICD-10 Finland

Cytomegaloviral pneumonitis

+∞

8.3

PBU81

NOMESCO Finland

Thrombectomy in arteriovenous fistula from artery of upper extremity

+∞

8.3

58399

ICD-8 Finland

Nephritis, unqualified

+∞

8.3

N04.0

ICD-10 Finland

Nephrotic syndrome, minor glomerular abnormality

+∞

8.3

KA2DE, ,

NOMESCO Finland

+∞

8.3

C92.9

ICD-10 Finland

Myeloid leukaemia, unspecified

+∞

8.3

742, ,

NOMESCO Finland

+∞

8.3

WA010

NOMESCO Finland

Adjuvant whole body radiotherapy

+∞

8.3

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

10.9

8.3

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

4.2

8.3

XF602

NOMESCO Finland

Bloodpressure monitoring

7.2

8.3

JAH01

NOMESCO Finland

Laparoscopy

2.8

8.3

146

N02BE01

ATC

paracetamol; systemic, rectal

2.0

8.2

661

5935

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.3

8.2

268

UJF02

NOMESCO Finland

Peroral enteroscopy

14.7

8.2

KA3EB

NOMESCO Finland

Antegrade pyelography

14.7

8.2

R06.0

ICD-10 Finland

Dyspnoea

1.7

8.2

197

1318

M87.0

ICD-10 Finland

Idiopathic aseptic necrosis of bone

7.7

8.2

C10AA04

ATC

fluvastatin; oral

2.3

8.2

295

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

2.3

8.2

269

S18

ICPC

Laceration/cut

1.6

8.1

351

2703

H3600, E103,

ICD-10 Finland

6.9

8.1

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

33.7

8.1

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.4

8.1

238

C03DA01

ATC

spironolactone; oral

2.0

8.1

462

ZYC01

NOMESCO Finland

Remote contact by phone

2.3

8.1

264

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.3

8.1

277

R80

ICD-10 Finland

Isolated proteinuria

10.2

8.1

K50.9

ICD-10 Finland

Crohn disease, unspecified

4.2

8.0

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

4.2

8.0

RJ210, ,

NOMESCO Finland

22.3

8.0

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

3.9

8.0

TQW40

NOMESCO Finland

Remowal of suture of skin

2.3

7.9

279

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

6.7

7.9

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.8

7.9

138

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

7.9

K72.9

ICD-10 Finland

Hepatic failure, unspecified

13.2

7.9

C09AA05

ATC

ramipril; oral

1.7

7.9

174

1138

H26.02

ICD-10 Finland

Presenil cataract

3.4

7.9

L57.0

ICD-10 Finland

Actinic keratosis

2.1

7.8

389

K12.18

ICD-10 Finland

Other forms of stomatitis

10.9

7.8

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

9.5

7.8

H36.09

ICD-10 Finland

Diabetic retinopathy (E10-E14+ with common fourth character .3)

9.5

7.8

UJK02

NOMESCO Finland

ERCP

3.7

7.8

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

3.6

7.8

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

6.5

7.7

KAS70

NOMESCO Finland

Inspection and preparation of kidney, pre-transplantation

45.5

7.7

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

45.5

7.7

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

45.5

7.7

Q61.0

ICD-10 Finland

Congenital single renal cyst

45.5

7.7

I79.2*E10.5

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

45.5

7.7

C83.00

ICD-10 Finland

Lymphocytic lymphoma

45.5

7.7

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.3

7.7

K01.0

ICD-10 Finland

Embedded teeth

4.4

7.7

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

8.1

7.6

D11AH01

ATC

tacrolimus; topical

6.8

7.6

H25.8

ICD-10 Finland

Other senile cataract

2.2

7.6

324

JN5JR

NOMESCO Finland

Extensive PET-CT of upper body metabolism (eyebrows to thighs)

18.6

7.6

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

18.6

7.6

306

Kela drug reimbursment

Erythropoietin and darbepoetin

18.6

7.6

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.2

7.6

331

C82.2

ICD-10 Finland

Follicular lymphoma grade III, unspecified

25.3

7.6

L84

ICD-10 Finland

Corns and callosities

3.1

7.6

108

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.5

7.6

195

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

9.0

7.6

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

9.0

7.6

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

4.3

7.5

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.8

7.5

131

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.2

7.5

286

ZJX00

NOMESCO Finland

Double balloon technique in gastroenterological endoscopy

80.9

7.4

ZX120, ,

SPAT

6.1

7.4

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

7.8

7.4

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.5

7.4

185

E83.51

ICD-10 Finland

Hypocalcemia

8.5

7.3

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

8.5

7.3

K74.3

ICD-10 Finland

Primary biliary cirrhosis

11.0

7.3

D46.7

ICD-10 Finland

Other myelodysplastic syndromes

11.0

7.3

ZXC40

NOMESCO Finland

Use of ultrasound

9.5

7.3

M31.1

ICD-10 Finland

Thrombotic microangiopathy

+∞

7.3

J05AX10, ,

ATC

+∞

7.3

9811/3-C42.1

ICD-O-3

B lymphoblastic leukemia/lymphoma, NOS, of bone marrow

+∞

7.3

L04AA18

ATC

[U] everolimus

+∞

7.3

58200

ICD-8 Finland

Chronic nephritis, Cum uraemia

+∞

7.3

2AX05, ,

NOMESCO Finland

+∞

7.3

KAB00

NOMESCO Finland

Biopsy of kidney or pelvis of kidney

+∞

7.3

D89.89

ICD-10 Finland

Other specified disorders involving the immune mechanism, not elsewhere classified

+∞

7.3

474, ,

NOMESCO Finland

+∞

7.3

PC2DE

NOMESCO Finland

Ultrasound examination of liver vasculature with Doppler method

+∞

7.3

K77.0*B25.1

ICD-10 Finland

Cytomegaloviral hepatitis

+∞

7.3

M01AC06

ATC

meloxicam; systemic, rectal

0.6

7.3

126

1944

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

7.3

243

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

7.3

472

WX730

NOMESCO Finland

Conventional respirator

5.9

7.3

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

5.9

7.3

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

5.9

7.3

M05BB03

ATC

alendronic acid and colecalciferol; oral

4.4

7.2

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

15.9

7.2

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

15.9

7.2

A02BC05

ATC

esomeprazole; systemic

1.5

7.2

286

2144

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

3.7

7.2

A10BH05

ATC

linagliptin; oral

2.7

7.2

151

AN1

Coronary angiography

2.1

7.2

352

WX702

NOMESCO Finland

Supraglottic ventilation device

2.3

7.2

251

RJ412, ,

NOMESCO Finland

30.3

7.2

WW402

NOMESCO Finland

Leucoferesis

30.3

7.2

RJ190, ,

NOMESCO Finland

30.3

7.2

H28.0*E10.3

ICD-10 Finland

Other specified diabetes mellitus - Diabetic cataract

20.2

7.1

L04AX06

ATC

pomalidomide; oral

20.2

7.1

ZXF00

NOMESCO Finland

Interruption caused by intraoperative deterioration of general condition

20.2

7.1

WX400

NOMESCO Finland

Inhalation anesthesy

2.7

7.1

152

Z01.9

ICD-10 Finland

Special examination, unspecified

2.3

7.1

239

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.1

7.1

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

7.1

109

641

K50.1

ICD-10 Finland

Crohn disease of large intestine

5.7

7.1

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

5.7

7.1

N43.3

ICD-10 Finland

Hydrocele, unspecified

3.7

7.1

K05.31

ICD-10 Finland

Periodontitis pronounced

1.9

7.1

521

SPAT1325

SPAT

Vaccination

1.6

7.1

216

1527

OAB43, ,

SPAT

0.6

7.0

114

1792

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.9

7.0

113

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.3

7.0

241

XX3DW

NOMESCO Finland

Time consuming IT work

1.9

7.0

464

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

6.4

7.0

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

13.9

6.9

602

Kela drug reimbursment

Children's severe malnutrition

8.4

6.8

SPAT1153

SPAT

Removal of sutures

1.6

6.8

218

1554

A40.8

ICD-10 Finland

Other streptococcal sepsis

6.8

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

6.8

107

633

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.0

6.8

438

C02EA01, ,

ATC

9.4

6.8

J94.8

ICD-10 Finland

Other specified pleural conditions

6.2

6.8

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

6.8

379

3043

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

5.7

6.8

5828A

ICD-9 Finland

Chronic glomerulonephritis, With other specified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA ALIA DEF,EI NEFR SDR]

40.4

6.8

B74

ICPC

Malignant neoplasm blood other

40.4

6.8

B00.2

ICD-10 Finland

Herpesviral gingivostomatitis and pharyngotonsillitis

16.9

6.8

N18

ICD-10 Finland

Chronic kidney disease

7.3

6.7

NF1AA

NOMESCO Finland

Hip X-ray examination

2.1

6.7

313

FQA10

NOMESCO Finland

Orthotopic transplantation of heart with bicaval anastomosis

22.7

6.7

N083, E102,

ICD-10 Finland

22.7

6.7

B72

ICPC

Hodgkin Lymphoma

22.7

6.7

ZXC50

NOMESCO Finland

Cryotherapy

3.1

6.7

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

4.1

6.7

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

4.1

6.7

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

2.1

6.6

314

N30.9

ICD-10 Finland

Cystitis, unspecified

2.3

6.6

214

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

7.9

6.6

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.8

6.6

570

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

3.3

6.6

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

6.6

571

N39.1

ICD-10 Finland

Persistent proteinuria, unspecified

8.8

6.6

N03AX14

ATC

levetiracetam; systemic

3.1

6.5

4059B

ICD-9 Finland

Secondary hypertension, Unspecified[HYPERTONIA SECUNDARIA ALIA DEFINITA]

70.4

6.4

L01BB01, ,

ATC

70.4

6.4

3A422, ,

NOMESCO Finland

70.4

6.4

9863/3-C42.1

ICD-O-3

Chronic myeloid leukemia, NOS, of bone marrow

70.4

6.4

2AX04, ,

NOMESCO Finland

70.4

6.4

BBA50

NOMESCO Finland

Total parathyroidectomy

70.4

6.4

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

7.5

6.4

WZC15, ,

NOMESCO Finland

7.5

6.4

N13.1

ICD-10 Finland

Hydronephrosis with ureteral stricture, not elsewhere classified

14.5

6.4

WX740

NOMESCO Finland

Nitrogen oxide therapy

14.5

6.4

L01AA02

ATC

chlorambucil; oral

14.5

6.4

A08.3

ICD-10 Finland

Other viral enteritis

14.5

6.4

TFJ02

NOMESCO Finland

Muscle biopsy of heart

14.5

6.4

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

6.4

516

N05BA06

ATC

lorazepam; systemic, sublingual

2.3

6.3

199

K05.30

ICD-10 Finland

Periodontitis complex

1.7

6.3

119

742

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

6.0

6.3

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

11.1

6.3

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

11.1

6.3

WX213

NOMESCO Finland

Lower leg blockade

9.4

6.3

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

9.4

6.3

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

6.3

221

1606

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.6

6.3

138

A01AB04

ATC

amphotericin B; local oral

2.6

6.3

138

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

18.2

6.3

D47.1

ICD-10 Finland

Chronic myeloproliferative disease

18.2

6.3

BB1BQ

NOMESCO Finland

Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT

18.2

6.3

I77.0

ICD-10 Finland

Arteriovenous fistula, acquired

18.2

6.3

JLE70

NOMESCO Finland

Inspection and preparation of pancreas, pre-transplantation

+∞

6.3

TCH12

NOMESCO Finland

Sample aspiration from anterior chambre

+∞

6.3

H30.0

ICD-10 Finland

Focal chorioretinal inflammation

+∞

6.3

B95.6

ICD-10 Finland

Staphylococcus aureus as the cause of diseases classified to other chapters

+∞

6.3

JA3FT

NOMESCO Finland

Exchange abdominal catheter with radiological guidance

+∞

6.3

RJ530, ,

NOMESCO Finland

+∞

6.3

PBM09

NOMESCO Finland

Closure of arteriovenous fistula of brachial artery

+∞

6.3

07951

ICD-8 Finland

Other viral diseases, Virosis cytomegalica asquisita

+∞

6.3

D638, N180,

ICD-10 Finland

+∞

6.3

C92.5

ICD-10 Finland

Acute myelomonocytic leukaemia

+∞

6.3

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.4

6.3

175

P01AB01

ATC

metronidazole; oral, rectal

1.5

6.2

281

2150

RJ425, ,

NOMESCO Finland

26.9

6.2

PB1BC

NOMESCO Finland

Extensive angiography of upper extremity with X-ray

26.9

6.2

H30.9

ICD-10 Finland

Chorioretinal inflammation, unspecified

26.9

6.2

B73

ICPC

Leukaemia

26.9

6.2

3A064, ,

NOMESCO Finland

26.9

6.2

XFE00

NOMESCO Finland

Epicardial ultrasonography

3.7

6.2

ZZA00

NOMESCO Finland

Split skin graft

3.2

6.2

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

6.4

6.2

A01AB09

ATC

miconazole; local oral

2.1

6.2

295

K86.2

ICD-10 Finland

Cyst of pancreas

5.8

6.2

RS222, ,

NOMESCO Finland

5.8

6.2

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.1

6.2

268

T93

ICPC

Lipid disorder

0.2

6.1

313

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

3.8

6.1

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

2.2

6.1

229

SPAT1229

SPAT

Assessment of need for aid

2.3

6.1

216

J01XX08

ATC

linezolid; systemic

8.7

6.1

C02DE02, ,

ATC

8.7

6.1

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

10.1

6.0

R53

ICD-10 Finland

Malaise and fatigue

1.6

6.0

176

1225

WVA20, ,

SPAT

2.6

6.0

141

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

309

173

29.68

307.65

1.8

1.4

246.37

244.59

u/ml

0.02

214

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

231

37.06

307.65

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

317

160

33.59

307.65

2.6

1.6

128.99

142.17

au/ml

0.56

104

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

231

35.07

307.65

2.5

2.4

20.13

19.37

iu/ml

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

331

261

21.91

307.65

1.8

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

340

170

35.76

307.65

2.5

1.5

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

494

168

84.22

307.65

22.4

5.5

4052.32

228.47

iu/ml

1.11

301

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

411

131

68.20

307.65

6.0

4.6

6458.71

2701.81

u/ml

0.29

(40768446) Kidney Pathology biopsy report

159

83.80

297.18

2.5

1.9

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

482

889

13.37

294.37

35.2

6.4

1.13

1.04

mmol/l

6.88

475

834

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

430

724

12.58

280.55

13.6

5.2

277.98

241.58

u/l

3.85

423

695

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

183

34.26

274.21

1.6

1.5

54.34

88.17

—

(3042733) HLA Ab [Presence] in Serum

141

64.08

251.99

5.9

3.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

322

472

11.20

229.21

3.6

1.6

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

128

51.24

218.61

1.2

1.0

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

247

269

13.20

217.98

3.3

2.0

1.45

1.52

g/l

0.40

226

239

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

223

210

14.69

216.39

4.1

1.9

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

220

203

14.92

216.20

3.8

1.8

—

(3024932) HLA-DR beta [Type]

121

55.30

210.47

1.1

—

(3024471) HLA-A [Type]

121

53.24

208.73

1.0

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

205

183

15.04

205.09

4.8

6.2

0.25

0.36

iu/ml

3.47

106

101

(3023520) Reticulocytes [#/volume] in Blood

327

553

9.71

204.67

7.8

3.0

72.81

72.64

e9/l

0.02

243

401

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

298

469

9.88

197.52

15.5

4.1

190.02

78.16

ng/l

21.69

286

426

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

108

69.93

196.92

1.2

1.1

—

(3027945) Reticulocytes/Erythrocytes in Blood

362

718

8.81

195.67

8.4

3.1

2.12

1.78

4.72

355

658

(3005719) IgG [Mass/volume] in Serum or Plasma

328

596

9.00

191.44

7.2

2.5

8.47

10.50

g/l

10.75

318

553

(3017143) Hepatitis C virus Ab [Presence] in Serum

394

879

8.34

189.88

3.5

1.6

—

(3023368) Bacteria identified in Blood by Culture

558

1771

9.40

189.50

14.4

4.3

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

449

1149

8.25

189.07

16.0

4.1

0.79

0.82

mmol/l

7.14

443

1096

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

432

1065

8.21

188.69

5.0

2.0

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

418

1019

8.01

183.76

9.6

2.5

2.04

2.35

g/l

25.02

412

955

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

371

806

8.13

182.35

3.8

1.9

—

(3022948) Iron [Moles/volume] in Serum or Plasma

425

1087

7.72

176.86

9.6

2.5

12.10

13.63

umol/l

4.29

419

1027

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

421

1083

7.58

173.59

3.6

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

190

194

12.78

173.05

2.1

1.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

354

769

7.82

172.73

3.9

2.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

174

178

12.43

157.64

2.6

1.6

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

136

17.64

156.74

1.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

381

983

6.85

153.36

5.4

2.8

29.38

29.54

0.16

375

958

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

152

133

14.08

152.14

4.6

1.9

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

289

580

7.48

149.85

2.4

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

440

1321

6.64

149.61

3.6

2.0

—

(3012544) pH of Venous blood

312

684

7.10

147.99

18.5

4.5

7.36

7.38

5.47

244

378

(3028026) IgM [Mass/volume] in Serum or Plasma

262

482

7.82

147.40

3.0

1.6

1.21

1.34

g/l

0.41

242

446

(3002032) Base excess in Venous blood by calculation

302

654

7.06

144.66

19.3

4.5

0.63

1.76

mmol/l

5.47

266

563

(3021447) Carbon dioxide [Partial pressure] in Venous blood

304

683

6.80

139.69

19.1

4.4

5.76

5.74

kpa

0.08

298

666

(3026493) Urate [Moles/volume] in Serum or Plasma

495

1733

6.46

139.21

10.3

2.8

368.23

344.71

umol/l

4.18

484

1543

(42870588) Differential panel, method unspecified - Blood

573

2301

7.31

137.39

25.5

6.8

—

(3042936) Bacteria identified in Isolate by Culture

365

986

6.26

137.34

3.7

2.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

128

100

15.23

136.61

3.1

1.8

—

(3011412) CD3 cells [#/volume] in Blood

114

18.49

136.33

4.8

2.0

1410.33

1175.28

e6/l

0.88

103

(3002179) Metamyelocytes/Leukocytes in Blood

277

587

6.90

134.60

11.9

4.9

0.72

0.52

1.15

227

178

(3017181) Myelocytes/Leukocytes in Blood

284

621

6.75

133.54

12.0

4.9

0.85

0.90

0.13

232

200

(44806118) Parainfluenza type 4 nucleic acid detection

136

122

13.40

133.47

2.6

1.7

—

(44790049) Parainfluenza type 3 nucleic acid detection

136

122

13.40

133.47

2.6

1.7

—

(44790048) Parainfluenza type 2 nucleic acid detection

136

122

13.40

133.47

2.6

1.7

—

(44790047) Parainfluenza type 1 nucleic acid detection

136

122

13.40

133.47

2.6

1.7

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

187

267

9.00

130.66

3.4

2.0

1.74

2.43

ug/l

0.25

179

244

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

143

144

12.03

130.02

2.6

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

128

114

13.33

125.98

3.2

1.9

—

(3018418) pH of Serum or Plasma

506

1926

6.00

125.40

28.2

4.1

7.39

7.40

1.29

453

1366

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

121

103

13.82

122.37

3.0

1.7

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

20.11

121.86

5.6

2.2

200.73

227.60

e6/l

0.38

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

107

16.70

121.81

2.5

1.7

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

119

104

13.41

118.31

8.8

6.9

11.48

10.35

mg/l

1.43

110

(3004809) Band form neutrophils/Leukocytes in Blood

118

102

13.54

118.11

9.6

3.7

1.33

1.39

0.05

112

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

124

117

12.50

117.37

2.6

1.7

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

141

161

10.55

116.87

2.2

1.8

—

(3000850) Epithelial cells [#/volume] in Urine

423

1455

5.37

116.29

10.3

2.6

3.39

5.47

e6/l

2.56

414

1330

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

134

144

11.11

116.03

2.5

1.7

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

607

2840

6.96

113.96

31.6

5.2

33.86

36.16

g/l

21.07

596

2691

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

36.10

113.51

4.4

2.5

0.59

0.61

mmol/l

0.52

(3020630) Protein [Mass/volume] in Serum or Plasma

238

509

6.38

112.69

7.0

2.9

61.98

67.26

g/l

14.30

229

480

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

19.04

111.72

3.8

2.2

—

(4035726) Immunohistochemistry procedure

249

570

6.04

109.34

2.5

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

157

228

8.44

107.12

3.6

2.9

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

262

639

5.76

107.03

5.3

3.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

18.09

104.36

5.2

2.0

859.63

482.29

e6/l

2.32

(3026782) Osmolality of Urine

362

1223

4.79

98.41

11.2

2.8

459.89

541.39

mosm/kgh2o

15.66

350

1078

(3004119) Hemoglobin [Mass/volume] in Venous blood

202

419

6.23

97.68

14.2

3.7

108.02

130.43

g/l

37.31

197

410

(3011648) Oxygen content in Venous blood

13.63

96.01

10.2

4.7

11.09

10.62

0.41

(3019069) Monocytes/Leukocytes in Blood

624

3245

6.49

95.88

28.8

7.0

8.95

8.90

0.18

619

3054

(3002582) Erythrocytes [#/volume] in Urine

492

2130

4.81

95.54

13.7

3.3

32.16

74.75

e6/l

0.74

454

1627

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

16.54

95.26

3.2

2.5

30.29

38.31

1.83

(3022096) Basophils/Leukocytes in Blood

622

3238

6.40

95.08

28.5

6.9

0.60

0.70

4.90

617

3037

(3006504) Eosinophils/Leukocytes in Blood

622

3240

6.39

94.95

28.3

6.8

2.18

2.88

14.07

617

3045

(3009343) pH of Capillary blood

215

485

5.81

94.77

11.1

5.0

7.41

7.42

1.93

197

404

(36304419) Bacteria [Presence] in Urine

438

1752

4.61

94.25

11.4

3.1

—

0.00

estimate

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

618

3224

6.21

93.50

57.1

8.1

1.21

mmol/l

0.04

586

2809

(3025159) Blasts/Leukocytes in Blood

238

595

5.39

93.23

12.9

5.4

0.42

0.13

0.42

188

150

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

223

527

5.60

93.18

7.3

2.5

39.09

70.48

ml/min/173m2

22.86

121

224

(3030467) Casts [#/volume] in Urine by Automated count

446

1835

4.53

91.69

12.7

3.2

0.30

0.39

e6/l

0.27

395

1335

(3024354) Oxygen [Partial pressure] in Venous blood

235

594

5.31

90.64

14.3

4.0

5.79

4.60

kpa

9.44

230

580

(3021440) Promyelocytes/Leukocytes in Blood

234

591

5.30

90.31

12.9

5.0

0.09

0.14

0.70

184

167

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

151

253

7.22

89.92

2.5

1.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

195

425

5.85

88.84

10.7

5.1

0.95

1.56

mmol/l

1.34

142

323

(3006315) Basophils [#/volume] in Blood

641

3524

6.64

88.77

24.8

6.8

0.03

0.04

e9/l

10.05

605

3024

(3001604) Monocytes [#/volume] in Blood

640

3518

6.59

88.52

24.9

6.8

0.60

0.58

e9/l

1.04

605

3016

(1616796) Gas panel - Central venous blood

111

132

9.70

88.48

10.4

3.0

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

474

2108

4.39

85.84

8.7

2.6

55.79

63.53

u/l

1.45

460

1968

(3019198) Lymphocytes [#/volume] in Blood

642

3588

6.48

85.56

25.4

6.9

1.92

2.02

e9/l

0.23

613

3169

(3045142) Bone marrow Pathology biopsy report

11.41

85.53

1.9

1.4

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

405

1628

4.23

84.16

3.7

2.2

2.94

2.85

mg/l

0.33

377

1412

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

317

1070

4.40

83.95

8.3

3.0

2.00

2.03

e6/l

0.02

200

517

(3013115) Eosinophils [#/volume] in Blood

643

3642

6.37

83.02

27.2

7.2

0.15

0.19

e9/l

12.23

610

3183

(3004588) Protein electrophoresis panel - Serum or Plasma

185

410

5.66

82.32

6.4

2.6

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

129

203

7.47

81.09

8.4

4.0

75.50

78.14

mg/l

0.03

108

176

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

129

203

7.47

81.09

8.4

4.0

43.27

40.42

mg/l

0.11

108

177

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

134

223

7.10

79.92

2.5

1.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

264

804

4.52

79.64

2.5

1.7

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

327

1171

4.18

79.00

7.4

2.9

0.70

0.95

e6/l

1.00

212

613

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

118

173

7.91

78.96

2.3

1.6

—

(3037756) Immunofixation for Serum or Plasma

105

134

8.95

78.94

3.6

1.7

—

(3032080) INR in Blood by Coagulation assay

561

2928

4.63

78.63

26.6

11.6

1.17

1.20

inr

0.64

504

2411

(3018095) Leukocytes [#/volume] in Urine

504

2446

4.23

78.15

16.6

3.9

160.52

98.21

e6/l

0.51

459

1708

(3016502) Oxygen saturation in Arterial blood

236

674

4.65

77.11

16.6

11.8

94.58

95.79

1.58

226

656

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

259

797

4.44

76.72

13.8

3.3

9.55

8.25

umol/l

0.40

241

712

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

101

129

8.89

75.81

16.2

3.1

15.86

8.49

pmol/l

4.90

101

129

(3019977) pH of Arterial blood

247

744

4.46

75.08

16.9

11.2

7.42

7.41

1.06

131

414

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

247

748

4.43

74.48

16.9

11.1

4.89

5.12

kpa

3.31

236

726

(3027801) Oxygen [Partial pressure] in Arterial blood

247

748

4.43

74.48

16.9

11.1

11.69

12.49

kpa

1.69

234

727

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

119

189

7.30

73.94

7.9

3.6

9.26

2.30

ratio

1.09

112

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

10.43

73.85

5.0

1.9

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

11.09

72.93

5.1

2.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

11.65

72.78

3.8

2.7

1.82

1.30

g/24h

0.65

(3013650) Neutrophils [#/volume] in Blood by Automated count

647

3878

5.87

72.46

41.4

10.5

3.87

4.01

e9/l

0.90

616

3366

(3000093) Morphology [Interpretation] in Blood Narrative

12.73

72.40

1.6

1.1

—

(3000494) Fungus identified in Specimen by Culture

272

906

4.14

71.69

3.3

1.5

—

(3003396) Base excess in Arterial blood by calculation

240

734

4.34

71.05

16.7

11.3

-0.48

0.79

mmol/l

4.50

204

618

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

382

1622

3.76

70.15

6.7

2.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

218

634

4.44

68.79

18.4

11.8

107.36

121.84

g/l

18.68

210

623

(3044640) Blood type and Crossmatch panel - Blood

447

2128

3.72

68.27

8.5

2.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

15.35

68.01

1.9

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

100

144

7.86

67.68

4.8

2.1

119.10

132.34

g/l

4.93

112

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

123

222

6.43

67.36

4.8

2.9

208.92

190.98

1.07

118

215

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

9.86

66.98

1.7

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

100

147

7.70

66.43

2.6

1.5

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

151

335

5.39

66.27

2.0

1.4

—

(3026008) Bacteria identified in Urine by Culture

392

1742

3.62

66.12

6.3

2.9

—

(3008536) Aspergillus sp Ab [Presence] in Serum

28.10

65.83

4.5

1.6

—

(3036489) Thrombin time

134

273

5.76

64.57

4.1

3.0

22.37

21.27

0.84

128

256

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

157

369

5.12

64.35

13.8

3.4

0.69

0.61

1.18

157

369

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

160

386

5.00

63.53

21.7

14.7

14.08

15.93

11.36

153

374

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

533

2941

3.81

62.67

5.9

2.5

75.00

75.30

nmol/l

0.10

527

2667

(21494814) CD8 cells/Lymphocytes in Specimen

21.73

62.31

2.9

1.7

44.00

32.00

1.88

(3017354) Segmented neutrophils/Leukocytes in Blood

10.75

61.32

11.0

3.6

55.32

55.91

0.06

(3023183) Ammonium ion [Moles/volume] in Plasma

100

163

6.92

60.28

5.8

3.2

31.72

34.16

umol/l

0.41

147

(3013826) Glucose [Moles/volume] in Serum or Plasma

620

3838

4.55

60.16

27.9

5.7

6.85

6.66

mmol/l

1.32

607

3664

(3037692) Legionella sp identified in Specimen by Organism specific culture

17.21

59.48

2.1

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

106

186

6.47

59.47

2.1

1.2

—

(3025941) Bacteria identified in Stool by Culture

149

365

4.85

57.77

1.7

1.3

—

(21494434) Karyotype in Bone marrow

10.69

57.68

1.6

1.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

129

280

5.36

57.67

12.0

3.6

24.02

24.99

mmol/l

1.95

123

270

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

209

664

3.98

57.44

4.6

2.4

0.21

0.22

g/l

0.18

200

625

(3000012) Reticulocyte production index

10.01

57.41

4.8

2.6

0.95

1.05

0.49

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

138

7.18

56.12

1.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

337

1481

3.32

55.65

2.6

1.4

2.06

2.41

g/l

2.75

273

935

(3036481) Cortisol [Moles/volume] in Serum or Plasma

212

698

3.84

55.11

3.1

2.1

328.33

366.28

nmol/l

1.44

203

662

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

12.85

54.49

3.4

1.9

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

528

3056

3.46

54.02

8.9

2.8

—

estimate

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

149

385

4.58

53.85

2.9

1.7

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

9.52

53.00

10.7

3.8

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

13.32

51.67

2.6

1.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

372

1795

3.13

51.35

2.2

1.6

18.02

20.36

nmol/l

2.30

347

1519

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

9.43

50.30

4.2

2.5

33.05

32.93

0.07

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

13.04

50.01

2.7

1.2

—

(3012501) Base excess in Blood by calculation

115

7.24

48.87

11.0

3.7

2.51

2.54

mmol/l

0.01

(3016650) Hepatitis A virus Ab [Presence] in Serum

149

6.39

48.61

1.2

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

13.55

48.11

3.0

1.9

—

(3035933) Granulocytes/Leukocytes in Blood

156

6.18

47.48

7.7

3.2

53.04

56.84

1.29

156

(3019832) Treponema pallidum Ab [Presence] in Serum

191

643

3.64

47.36

2.5

1.8

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

413

2186

2.98

47.10

12.6

3.5

2.31

2.36

mmol/l

6.20

400

2003

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

9.30

46.69

1.1

1.0

—

(3021589) Normoblasts [#/volume] in Blood

511

3049

3.12

46.59

46.0

11.4

0.01

0.00

e9/l

0.62

434

2478

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

9.41

46.33

5.2

2.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

102

217

5.28

46.29

5.7

2.6

1.09

1.07

g/l

0.02

199

(3031040) Bacteria [#/volume] in Urine by Automated count

621

4163

3.86

46.29

12.0

4.3

63.27

692.32

e6/l

0.60

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

13.29

45.55

3.0

1.9

—

(3000060) B lymphocytes [#/volume] in Blood

15.59

45.38

4.5

2.1

0.27

0.39

e9/l

0.34

(3006922) Hepatitis E virus Ab [Presence] in Serum

9.79

45.31

1.2

1.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

188

644

3.56

45.20

6.6

2.4

41.33

109.85

u/l

0.44

172

543

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

12.92

44.78

1.1

1.0

1591.64

1465.78

miu/ml

0.23

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

10.64

44.68

1.2

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

10.64

44.68

1.2

1.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

11.89

44.38

2.9

1.8

—

(3012516) Albumin [Mass/volume] in Urine

403

2160

2.87

43.97

10.3

3.4

128.19

47.16

mg/l

3.06

354

1387

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

15.96

43.67

7.2

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

15.96

43.67

7.2

2.1

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

428

2390

2.84

42.80

12.3

3.5

35.98

33.19

u/l

0.43

419

2265

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

15.34

42.77

7.2

2.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

8.65

41.93

5.8

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

8.65

41.93

5.8

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

8.65

41.93

5.8

1.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

404

2206

2.80

41.93

11.7

4.1

26.35

8.28

mg/mmol

4.26

347

1364

(3022313) Gas panel - Capillary blood

128

355

4.14

41.61

13.1

5.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

81.68

41.38

10.3

4.3

5.14

6.28

mmol/l

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

377

2008

2.76

40.74

4.2

2.2

123.53

238.15

u/l

2.68

363

1917

(3017817) Protein [Mass] in Urine collected for unspecified duration

10.17

40.74

3.7

3.1

1332.98

1026.65

0.38

(40760892) CBC W Ordered Manual Differential panel - Blood

326

1612

2.81

40.74

15.3

5.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

101

237

4.77

40.69

4.0

2.2

276.75

264.72

ug/l

0.08

225

(3019309) Folate [Moles/volume] in Red Blood Cells

233

963

3.06

40.59

2.1

1.7

1296.73

1180.38

nmol/l

0.98

201

746

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

9.05

40.41

1.6

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

138

5.93

39.72

1.8

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

12.37

39.71

7.2

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

12.37

39.71

7.2

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

12.37

39.71

7.1

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

12.37

39.71

7.2

1.9

—

(21494890) Protein electrophoresis panel - 24 hour Urine

9.29

39.69

3.6

2.8

—

(3009508) Creatinine [Moles/volume] in Urine

418

2374

2.72

39.33

10.4

3.3

5.99

8.17

mmol/l

26.86

404

2015

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

311

1529

2.77

38.92

4.1

2.0

2.47

1.20

mg/l

1.60

285

1187

(3037467) Urinalysis macro (dipstick) panel - Urine

628

4435

3.56

38.79

17.0

4.2

—

3.45

—

(40768441) Liver Pathology biopsy report

9.71

37.76

3.7

1.4

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

109

288

4.26

37.67

11.7

6.9

1.61

1.57

0.18

100

274

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

10.53

37.45

1.8

2.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

10.53

37.45

1.8

2.1

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

350

1854

2.66

37.39

6.1

3.4

3665.36

939.84

ng/l

6.99

330

1549

(3008152) Bicarbonate [Moles/volume] in Arterial blood

128

383

3.82

37.21

13.2

9.1

23.54

24.52

mmol/l

1.82

120

367

(3009445) Proteinase 3 Ab [Units/volume] in Serum

111

300

4.17

37.20

2.7

1.4

19.49

13.26

iu/ml

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

8.52

37.09

1.2

1.1

—

(3017732) Neutrophils [#/volume] in Blood

215

890

2.98

36.92

6.4

3.2

4.21

5.48

e9/l

1.03

199

791

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

239

4.51

36.67

1.9

1.5

0.06

0.04

iu/ml

0.09

(3015736) pH of Urine

464

2839

2.66

36.55

8.9

3.3

6.26

6.19

0.72

262

1634

(40758558) Short blood count panel - Blood

368

2016

2.62

36.44

24.9

6.6

—

(3003181) Sodium [Moles/volume] in Urine

113

6.20

36.43

1.7

1.3

55.28

63.45

mmol/l

0.75

100

(3003694) ABO and Rh group [Type] in Blood

356

1936

2.60

35.57

2.0

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

11.07

35.13

2.9

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

11.07

35.13

2.9

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

256

4.30

35.12

12.7

7.5

0.93

0.87

0.35

242

(3028433) Virus identified in Specimen by Culture

13.14

35.11

1.6

1.5

—

(3021601) Nitrite [Presence] in Urine by Test strip

528

3505

2.71

34.17

12.6

3.6

0.00

estimate

-0.00

167

708

(3009261) Glucose [Presence] in Urine by Test strip

533

3557

2.72

34.08

12.6

3.6

0.00

0.02

estimate

1.32

165

654

(40768795) Lymph node Pathology biopsy report

7.64

33.85

1.7

1.2

—

(3051651) Icteric interference index of Serum or Plasma

9.77

33.84

7.8

3.3

0.88

0.84

index

0.05

(3035350) Ketones [Presence] in Urine by Test strip

529

3531

2.69

33.57

12.7

3.6

16.55

0.00

estimate

0.80

168

715

(3044290) Cell count panel - Cerebral spinal fluid

139

5.37

33.05

2.5

1.4

—

(3047181) Lactate [Moles/volume] in Blood

179

4.82

33.04

14.5

10.1

1.20

1.27

mmol/l

0.41

159

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

7.36

32.13

1.5

1.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

253

1218

2.63

31.84

7.6

4.0

625.20

446.45

ng/l

0.33

224

918

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

444

2772

2.47

31.76

2.6

2.0

96.51

95.58

pmol/l

0.18

286

1484

(3003434) Protein [Mass/volume] in Pleural fluid

7.53

30.82

1.6

1.5

27.40

32.53

g/l

1.46

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

36.30

29.91

2.4

1.4

—

(3039000) Anion gap in Blood by calculation

125

5.32

29.63

15.7

12.3

11.37

11.11

mmol/l

0.25

115

(3018572) Chloride [Moles/volume] in Blood

125

5.32

29.63

15.7

12.3

104.20

105.87

mmol/l

1.28

115

(3007566) Smooth muscle Ab [Titer] in Serum

227

4.10

28.73

1.4

1.2

94.44

94.35

titre

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

243

3.97

28.41

2.5

1.5

0.25

0.24

g/l

0.60

231

(3023419) Bacteria identified in Sputum by Culture

101

5.68

27.98

2.8

3.3

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

11.12

27.93

4.9

1.8

211.40

109.30

ng/l

1.25

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

124

434

3.23

27.89

7.4

3.8

251.60

166.98

ng/l

1.59

115

394

(3023199) Leukocytes [#/volume] in Pleural fluid

7.63

27.80

1.3

1.4

909.59

3224.26

e6/l

1.41

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

157

4.66

27.72

2.1

1.2

3.99

3.76

mmol/l

0.59

148

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

11.56

27.70

1.2

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

160

4.57

27.07

2.4

1.4

194.16

853.83

e6/l

0.43

120

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

157

4.59

26.80

2.4

1.3

3.64

15.26

e6/l

1.08

114

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

109

5.37

26.76

1.9

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

109

5.37

26.76

1.9

1.4

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

10.38

26.64

3.4

1.8

64.01

67.17

ug/l

0.06

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

6.89

26.63

1.2

1.1

256.25

62.86

titre

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

103

5.46

26.34

4.1

1.4

—

(3017704) Immunofixation for Urine

9.24

26.11

3.6

2.1

—

(3037522) Nuclear Ab [Titer] in Serum

212

1019

2.51

26.01

1.7

1.4

487.06

493.69

titre

0.02

225

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

105

5.36

25.79

4.1

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

105

5.36

25.79

4.1

1.4

—

(3048689) Calprotectin [Mass/mass] in Stool

198

936

2.52

25.07

3.9

2.5

235.09

119.27

ug/g

4.59

179

749

(3052851) Hemolysis interference index of Serum or Plasma

188

4.13

25.03

6.8

2.9

5.38

1.88

index

2.45

110

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

28.68

24.65

4.2

3.6

33.52

18.90

mg/l

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

28.68

24.65

2.7

1.5

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

387

2455

2.19

24.27

5.8

3.6

67.78

60.27

ng/l

0.09

329

1707

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

297

3.43

24.13

14.3

5.8

23.88

24.81

mmol/l

2.44

284

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

100

5.29

24.06

4.3

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

100

5.29

24.06

4.2

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

199

3.96

23.91

1.5

2.4

12.45

11.79

mg/l

0.23

189

(3005988) Vibrio sp identified in Specimen by Organism specific culture

101

5.23

23.79

4.3

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

235

3.64

22.81

1.2

1.4

207.32

227.53

miu/ml

0.15

115

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

624

4886

2.65

22.68

11.1

4.3

21.23

10.77

mm/h

30.18

612

4582

(3037121) Protein [Mass/volume] in Urine

251

3.55

22.68

8.9

4.1

1113.51

249.58

mg/l

1.23

126

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

106

4.98

22.51

1.5

1.3

4.72

4.29

u/ml

0.08

(3001964) Herpes simplex virus Ag [Presence] in Specimen

24.81

22.32

3.4

2.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

195

3.80

21.45

1.5

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

8.11

21.40

4.0

1.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

196

3.78

21.29

1.5

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

197

3.76

21.13

1.5

1.1

—

(3042631) Mycobacterium sp identified in Specimen

5.31

20.94

2.3

3.2

—

(3012441) Differential panel - Pleural fluid

6.55

20.71

1.6

1.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

8.04

20.53

1.3

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

123

506

2.71

20.37

2.7

2.3

16.11

7.63

ug/l

1.18

110

458

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

103

4.80

20.35

1.4

1.3

2.04

4.12

u/ml

0.45

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

33.60

20.30

2.6

6.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

267

3.28

19.89

1.5

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

5.50

19.86

2.0

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

258

3.30

19.69

1.6

1.7

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

5.17

19.44

1.2

1.3

—

(3047189) Immunofixation for 24 hour Urine

8.59

19.35

2.8

1.7

—

(3045788) Cell count panel - Pleural fluid

6.69

19.32

1.5

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

210

3.52

19.20

1.5

1.4

273.87

298.85

ug/g

0.44

127

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

7.42

19.19

1.3

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

229

3.37

18.71

7.4

1.9

—

(3029937) Albumin [Presence] in Urine by Test strip

306

1920

2.00

18.25

12.9

3.7

0.00

0.01

estimate

1.15

152

665

(3028308) Erythrocytes [#/volume] in Pleural fluid

6.34

17.77

1.4

12490.18

27901.61

e6/l

0.67

(40768804) Tissue Pathology biopsy report

372

2534

1.93

17.11

3.1

2.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

26.30

16.98

1.3

1.1

—

(3045414) Leukocytes [Presence] in Urine

135

631

2.39

16.94

6.0

2.0

0.00

0.04

estimate

0.78

139

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

133

3.96

16.89

1.5

1.2

102.61

18.39

u/l

1.59

116

(4195642) Thrombophilia screening test

4.48

16.84

1.2

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

4.94

16.75

1.5

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

214

3.29

16.61

3.9

1.7

—

(40757373) Influenza virus identified in Isolate

18.43

16.55

2.5

1.6

—

(3002256) Pathology report gross observation

161

830

2.20

15.96

1.4

1.3

—

(3045424) Erythrocytes [Presence] in Urine

353

2.73

15.68

6.3

2.1

0.00

0.03

estimate

0.68

119

(40768806) Pleura Pathology biopsy report

5.76

15.65

1.8

—

(40768797) Stomach Pathology biopsy report

171

912

2.13

15.51

1.4

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

162

3.51

15.34

19.9

1.6

1.08

0.83

nmol/l

1.50

136

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

29.29

15.25

2.1

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

4.56

14.87

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

217

1284

1.97

14.72

1.9

1.7

522.89

15279477.44

pmol/l

0.72

204

1093

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

5.09

14.63

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

157

3.48

14.63

5.4

2.6

306.94

81.03

ug/min

1.01

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

15.77

14.47

1.3

1.5

14.98

5.58

pmol/l

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

5.01

14.37

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

126

3.74

14.15

1.3

1.6

0.47

0.77

g/l

1.16

106

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

103

4.05

14.13

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

6.17

13.93

1.2

1.1

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

30.68

13.93

18.8

24.7

0.29

0.45

umol/l

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

127

635

2.20

13.43

3.6

4.6

24.98

29.43

ug/l

0.09

105

523

(3044889) 12 lead EKG panel

566

4603

1.94

13.42

7.5

3.9

—

10101.70

—

(3040151) Glucose [Moles/volume] in Capillary blood

4.60

13.42

3.3

8.9

6.76

7.25

mmol/l

0.39

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

537

4294

1.88

13.41

4.8

3.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

12.45

13.17

16.4

9.2

7.83

5.22

kpa

2.41

(40758292) HTLV I+II Ab panel - Serum

12.45

13.17

1.7

1.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

371

2674

1.77

12.98

12.0

3.5

0.67

0.02

estimate

0.48

149

590

(3023420) DNA double strand Ab [Units/volume] in Serum

315

2.61

12.72

2.5

1.9

13.59

7.93

iu/ml

0.38

(4268621) Lupus anticoagulant assay

4.35

12.56

2.6

2.4

—

(3022145) Colonoscopy Study observation

147

797

2.05

12.54

1.9

1.4

—

(40761536) Microorganisms panel - Urine sediment

107

513

2.27

12.49

15.3

3.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

5.76

12.48

8.9

3.2

1.57

1.20

0.43

(3024891) Influenza virus A+B Ag [Presence] in Specimen

185

3.07

12.40

1.5

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

219

2.89

12.32

1.3

—

(3048879) Bone marrow aspiration report

12.67

12.17

4.8

2.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

286

1949

1.76

11.88

11.5

3.0

1.68

0.01

estimate

0.49

149

564

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

566

4675

1.86

11.86

10.7

3.5

70.16

50.11

u/l

3.44

554

4450

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

9.14

11.82

1.0

1.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

4.86

11.73

1.2

1.1

99.15

107.96

pmol/l

0.37

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

267

2.66

11.66

3.1

3.7

123.91

4835.65

u/ml

0.71

234

(3020393) Adenovirus Ag [Presence] in Stool

17.36

11.23

2.1

1.8

—

(3052592) Norovirus Ag [Presence] in Stool

17.36

11.23

1.8

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

4.27

11.16

3.2

4.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

12.15

10.88

1.6

1.4

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

10.78

10.82

3.7

1.4

4684.14

5771.89

e6/l

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

18.13

10.76

4.8

3.8

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

127

3.27

10.42

3.1

4.1

759.38

2268.26

u/ml

0.34

120

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

5.24

10.36

1.4

1.1

—

(3049717) Cytology report of Urine Cyto stain

247

2.60

10.28

2.3

2.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

3.82

9.96

1.3

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

20.34

9.83

1.2

1.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

127

3.18

9.76

1.4

1.3

573.33

355.38

titre

—

(40765096) Chromosome analysis panel by Banding

7.97

9.67

1.2

1.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

3.89

9.57

1.4

1.3

1.87

2.84

g/l

2.07

(3027135) IgG subclass 1 [Mass/volume] in Serum

3.89

9.57

1.4

1.3

6.12

6.69

g/l

0.19

(3024139) IgG subclass 3 [Mass/volume] in Serum

3.89

9.57

1.4

1.3

0.47

0.33

g/l

0.86

(4062490) Immunoglobulin typing, IgG

3.89

9.57

1.4

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

339

2.31

9.57

1.5

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

4.36

9.17

1.2

1.5

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

501

2.05

8.96

2.4

8.80

15.90

au/ml

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

7.77

8.68

3.4

4.1

171.30

35.56

au/ml

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

7.77

8.68

1.4

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

182

2.69

8.67

1.6

1.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

8.35

8.61

2.1

2.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

7.06

8.59

1.1

—

(3004451) EKG impression Narrative

4.54

8.41

1.5

1.2

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

+∞

8.35

1.0

0.0

—

(3015956) Eosinophils/Leukocytes in Blood by Manual count

10.18

8.05

4.6

2.6

1.73

3.60

0.77

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

22.29

8.03

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

22.29

8.03

30.2

5.4

105.82

107.00

g/l

—

(3005322) IgE [Units/volume] in Serum or Plasma

499

1.99

8.02

1.8

1.3

450.53

272.80

u/ml

0.33

466

(3044007) Cell count panel - Peritoneal fluid

8.58

7.84

3.7

1.5

—

(21494755) Public health laboratory ask at order entry panel

734

0.33

7.77

1.0

1.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

181

1200

1.67

7.76

5.0

2.8

2.45

mmol/l

0.17

169

1091

(3014891) Appearance of Pleural fluid

18.58

7.62

1.6

1.5

—

(3044927) Protein electrophoresis panel - Urine

3.61

7.47

1.2

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

13.52

7.40

1.8

1.9

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

9.49

7.30

1.0

1.2

—

(3026480) Teichoate Ab [Titer] in Serum

+∞

7.30

1.0

0.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

15.91

7.24

1.1

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

3.62

7.19

1.2

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

6.42

6.97

1.9

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

3.41

6.88

2.9

2.4

23.28

9.28

umol/l

0.54

(40761539) Cells [Type] in Urine sediment by Light microscopy

9.43

6.80

1.8

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

232

2.29

6.73

2.0

1.5

10.27

8.15

u/l

0.64

188

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

292

2.15

6.73

2.4

—

(40768443) Skin Pathology biopsy report

280

2.16

6.64

1.4

1.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

7.90

6.63

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

8.80

6.57

1.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

698

6480

2.11

6.52

91.1

15.0

21.06

23.62

mg/l

2.20

683

5257

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

403

1.96

6.44

3.2

3.6

4.10

4.65

pmol/l

3.71

361

(3035637) Corticotropin [Mass/volume] in Plasma

3.04

6.44

1.6

1.5

24.24

27.56

ng/l

0.27

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

125

2.72

6.40

1.2

1.1

29.74

26.53

iu/ml

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

7.11

6.24

2.1

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

7.11

6.24

3.0

2.4

39.80

41.83

g/l

0.46

(3019150) Specific gravity of Urine by Refractometry

217

1574

1.53

6.21

9.9

3.6

1.02

kg/l

1.29

178

1042

(3021788) Differential panel - Synovial fluid

122

2.70

6.13

1.8

1.5

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

12.65

6.09

5.1

3.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

5.61

6.02

1.4

1.5

—

(3017569) Oxygen content in Arterial blood

5.09

5.90

1.6

3.4

14.75

17.42

1.98

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

6.46

5.88

1.8

1.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

572

5073

1.54

5.81

5.1

4.2

14.75

14.70

pmol/l

0.21

554

4678

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

11.24

5.80

5.3

3.7

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

9.28

5.80

2.4

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

9.28

5.80

2.4

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

9.28

5.80

2.4

1.3

—

(3034426) Prothrombin time (PT)

6.94

5.75

1.3

1.6

28.62

30.21

0.24

(3006571) Granulocytes/Leukocytes in Synovial fluid

3.09

5.69

2.1

1.6

53.87

56.19

0.09

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

7.60

5.65

1.2

1.3

—

(3023410) Appearance of Cerebral spinal fluid

2.99

5.62

3.4

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

805

0.46

5.59

2.2

2.0

3.59

3.60

ratio

0.03

649

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

204

2.23

5.58

1.7

2.1

935.59

5119.69

u/l

1.32

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

6.59

5.57

1.2

1.1

—

(3033799) Differential panel - Peritoneal fluid

6.59

5.57

1.8

1.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

6.59

5.57

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

10.12

5.54

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

16.16

5.42

1.1

2.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

113

2.63

5.36

1.1

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

208

2.18

5.34

1.3

1.2

2.18

2.67

u/ml

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

9.20

5.30

1.8

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

353

2886

1.42

5.27

3.0

2.0

1.57

1.39

mmol/l

3.38

333

2453

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

6.76

5.27

1.7

1.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

+∞

5.21

2.0

0.0

—

(3030703) Everolimus [Mass/volume] in Blood

+∞

5.21

17.0

0.0

4.24

—

ug/l

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

13.46

5.09

3.0

3.3

—

(3032057) Clostridioides difficile [Presence] in Stool

8.43

5.07

3.5

2.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

3.33

5.05

1.2

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

208

2.13

4.94

1.4

1.2

13.95

10.09

u/ml

—

(1761868) Lipid panel - Serum or Plasma

219

2798

0.69

4.88

4.3

3.1

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

594

0.42

4.84

2.0

1.8

3.74

3.48

mmol/l

0.56

439

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

5.27

4.78

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

2.73

4.62

3.0

3.1

1.09

0.91

nmol/l

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

14.11

4.58

1.6

1.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

216

1654

1.43

4.50

1.4

1.3

1.07

1.35

u/ml

0.34

472

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

5.56

4.30

5.2

3.1

6.91

4.40

ug/l

0.56

(3013005) Retinol [Moles/volume] in Serum or Plasma

4.18

4.22

1.8

2.2

1.78

2.01

umol/l

0.46

(3001019) Free T4 and TSH panel - Serum or Plasma

351

0.30

4.20

2.0

1.8

—

(3034988) Calcium [Moles/volume] in Capillary blood

6.99

4.17

2.3

7.5

1.21

1.20

mmol/l

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

5.30

4.15

1.2

—

(3036048) Francisella tularensis Ab [Titer] in Serum

5.95

4.14

1.1

—

(4024509) Urine culture

274

1.88

4.11

5.4

1.9

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

173

1291

1.44

4.11

1.8

1.6

—

(3003740) Influenza virus B Ag [Presence] in Specimen

150

2.18

4.02

1.5

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

10.08

4.01

1.1

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

151

2.17

3.95

1.5

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

7.84

3.56

2.0

1.4

—

(3025130) Human papilloma virus identified in Specimen

2.41

3.51

2.9

1.8

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

6.21

3.51

4.6

11.2

9.81

10.25

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

2.69

3.41

2.3

2.2

27.53

20.24

nmol/l

0.89

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

4.12

3.40

2.5

5.8

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

8.63

3.27

1.2

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

3.06

3.26

1.2

3.1

10.66

8.51

mmol/l

0.39

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.54

3.12

1.1

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

4.04

3.09

1.3

83.60

84.00

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

372

1.64

3.05

2.6

1.7

0.25

0.34

mg/l

0.49

179

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.88

3.02

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

3.88

2.99

1.2

2.1

98.80

88.07

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

148

2.00

2.98

1.6

1.8

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

10.05

2.98

9.4

5.8

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

10.05

2.98

1.0

1.8

—

(3004616) Nuclear Ab [Presence] in Serum

2.35

2.93

1.6

1.3

—

(1002224) Polysomnography panel

413

0.47

2.92

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.80

2.83

1.0

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

102

739

1.44

2.82

1.5

1.6

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

3.11

2.78

1.8

2.1

26.83

30.24

umol/l

0.37

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

5.04

2.73

1.9

1.4

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

3.48

2.70

10.8

3.0

350.00

189.48

u/l

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.17

2.65

1.3

2.1

62.50

79.86

umol/l

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

4.03

2.57

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

2.76

2.55

1.1

1.0

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

7.18

2.55

1.2

1.0

0.35

5.89

mmol/l

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

115

2.03

2.53

2.3

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

165

1.85

2.52

1.2

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

3.26

2.52

1.2

1.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

2.41

2.47

1.7

1.3

5.66

4.35

u/ml

—

(3033099) Centromere Ab [Titer] in Serum

6.28

2.37

1.0

1.3

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

262

1.64

2.32

3.3

1.1

0.96

0.91

g/l

0.72

262

(3028717) Thiamine [Mass/volume] in Blood

4.64

2.27

1.2

1.5

69.67

73.69

ug/l

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.58

2.21

1.2

1.4

—

(3006653) Thiamine [Moles/volume] in Blood

2.80

2.14

1.7

1.3

133.10

148.23

nmol/l

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

2.80

2.14

1.1

241.80

240.21

iu/ml

—

(3035285) Chloride [Moles/volume] in Venous blood

2.20

2.05

2.5

2.6

108.20

105.20

mmol/l

1.66

(3041354) Potassium [Moles/volume] in Venous blood

2.20

2.05

2.5

2.6

4.29

4.01

mmol/l

0.95

(3022689) Creatine [Moles/volume] in Urine

4.02

2.04

4.8

1.3

5.04

8.86

mmol/l

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

2.25

2.02

1.3

1.2

—

(3018333) Ribosomal P Ab [Presence] in Serum

2.25

2.02

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

2.52

2.02

1.3

1.4

—

27.80

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

2.21

1.95

1.1

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

160

1316

1.27

1.94

1.5

1.3

21.10

31.07

iu/ml

1.25

391

(3010015) Selenium [Moles/volume] in Serum or Plasma

4.57

1.94

2.0

1.7

1.16

1.19

umol/l

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

2.14

1.93

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

2.18

1.89

1.3

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

2.18

1.89

1.3

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

169

1.68

1.79

1.2

31.52

48.99

u/ml

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

2.11

1.77

1.3

1.1

—

(3022621) pH of Urine by Test strip

520

1.38

1.74

6.2

2.1

5.96

6.09

0.73

334

(3033705) Calcium.ionized [Moles/volume] in Venous blood

2.08

1.71

2.6

2.7

1.19

mmol/l

0.13

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

628

6018

1.27

1.62

6.3

5.1

1.99

1.89

mu/l

1.18

613

5580

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.59

1.62

1.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.02

1.58

3.5

4.0

11.44

10.41

kpa

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.02

1.58

3.5

4.1

4.75

4.95

kpa

—

(3002619) Bacteria identified in Specimen by Culture

2.87

1.51

1.2

1.1

—

(36660697) Celiac disease serology panel - Serum

553

1.33

1.47

1.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

354

1.41

1.46

1.1

—

31.57

titre

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.89

1.45

1.3

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

639

6155

1.26

1.44

13.0

6.1

40.00

39.07

mmol/mol

1.66

625

5808

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

651

6285

1.27

1.43

70.0

14.2

64.30

84.49

ml/min/173m2

48.90

633

5791

(4034850) Laboratory test

199

0.50

1.42

6.9

9.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

144

1.62

1.33

7.6

3.8

—

(3032773) Endomysium IgG Ab [Titer] in Serum

1.86

1.30

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

2.79

1.28

4.6

2.0

89.30

121.30

ng/l

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

253

0.58

1.26

1.3

1.1

1.43

1.52

g/l

0.44

253

(3051387) C reactive protein [Mass/volume] in Capillary blood

131

1.62

1.24

4.0

3.8

29.23

27.96

mg/l

0.07

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.41

1.24

4.0

2.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

189

0.52

1.24

1.7

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

2.01

1.23

1.3

1.8

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

640

6191

1.23

1.22

7.9

4.3

1.56

1.32

mmol/l

9.22

622

5761

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

107

892

1.23

1.18

1.8

1.5

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

2.51

1.15

2.4

3.4

31.60

43.10

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

2.51

1.15

4.8

6.8

14.20

8.45

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

2.01

1.12

1.1

—

(3027944) Amphetamines [Presence] in Urine

328

0.66

1.12

2.2

1.6

—

(3023511) Choriogonadotropin [Units/volume] in Urine

112

1.62

1.09

1.3

—

(3002079) Sodium [Moles/time] in 24 hour Urine

2.13

1.05

1.1

1.3

146.43

185.41

mmol/24h

—

(3036071) Salmonella sp Ab [Titer] in Serum

2.13

1.05

1.0

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

115

981

1.20

1.03

2.5

1.9

1.48

1.47

0.05

102

868

(3019420) Tryptase [Mass/volume] in Serum or Plasma

1.85

0.99

2.4

1.3

11.17

6.75

ug/l

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

302

1.34

0.97

1.6

1.9

38.15

38.82

nmol/l

0.05

288

(3016879) Cocaine [Presence] in Urine

306

0.68

0.97

3.2

1.7

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

1.75

0.97

3.2

3.3

21.53

3.31

nmol/l

0.50

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.81

0.97

1.3

1.1

—

(3028300) Cannabinoids [Presence] in Urine

328

0.69

0.96

3.1

1.7

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

126

1445

0.85

0.95

3.0

3.1

0.86

0.72

ug/l

0.88

878

(3027008) Opiates [Presence] in Urine

327

0.69

0.94

3.0

1.7

—

(3010813) Leukocytes [#/volume] in Blood

702

7125

0.77

0.93

117.0

23.1

7.02

6.69

e9/l

1.13

697

6977

(3026361) Erythrocytes [#/volume] in Blood

702

7125

0.77

0.93

116.8

23.0

4.00

4.56

e12/l

84.92

695

6981

(3043410) Blood group antigens tested for on Red Blood Cells

2.23

0.93

3.2

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

260

2386

1.14

0.92

4.3

5.1

1.98

2.12

ug/l

0.28

247

2159

(3000764) Benzodiazepines [Presence] in Urine

325

0.70

0.92

3.0

1.7

—

(3024263) Appearance of Synovial fluid

2.15

0.91

2.0

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

807

1.20

0.90

1.6

1.5

—

(3007461) Platelets [#/volume] in Blood

702

7121

0.78

0.87

117.2

23.1

222.54

250.34

e9/l

18.53

696

6997

(3000492) Spirometry study

738

1.20

0.85

2.9

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

166

0.60

0.84

1.9

1.5

—

(4281824) Cell count and differential, peritoneal fluid

1.70

0.82

1.6

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

105

1.54

0.82

1.6

1.0

—

(37208534) Antinuclear antibody arbitrary concentration in serum

1.88

0.82

1.2

1.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

175

1.38

0.75

2.0

3.82

4.89

iu/l

0.22

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

535

1.21

0.74

2.0

1.5

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

229

1.32

0.72

1.5

1.9

196.77

217.69

pmol/l

0.80

216

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.63

0.72

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.60

0.65

1.0

—

(40768800) Prostate Pathology biopsy report

154

0.64

0.65

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

0.00

0.59

0.0

1.0

—

9.94

—

(40761511) CBC panel - Blood by Automated count

682

6716

1.17

0.59

67.4

13.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

133

1207

1.12

0.57

1.4

1.3

4.31

11.91

u/ml

2.07

474

(3023323) Follitropin [Units/volume] in Serum or Plasma

340

1.22

0.55

2.4

1.4

28.66

25.04

iu/l

0.22

285

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

164

0.73

0.45

1.2

1.1

0.74

2.08

u/ml

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.62

0.43

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.62

0.43

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.62

0.43

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.62

0.43

1.0

1.1

—

(3020650) Glucose [Presence] in Urine

1.57

0.42

1.4

1.3

0.00

0.09

estimate

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

240

1.22

0.42

1.9

1.8

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

0.40

0.0

1.5

—

0.47

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

258

0.81

0.38

3.2

1.7

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

107

1.31

0.37

1.1

1.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

180

0.77

0.37

1.4

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

1.37

0.34

1.2

1.5

112.67

75.95

umol/l

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

616

6245

0.92

0.34

9.3

5.0

6.09

5.94

mmol/l

1.50

595

5780

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.28

0.26

1.9

1.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

149

0.80

0.26

1.0

8.19

6.53

u/ml

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

754

0.92

0.24

1.7

2.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1.27

0.24

1.5

1.3

0.45

0.61

nmol/l

1.39

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

485

1.10

0.24

1.2

176.25

139.32

u/ml

0.24

189

(3011985) Renin [Units/volume] in Plasma

1.25

0.22

1.7

1.3

52.05

71.60

mu/l

0.21

(3050129) First trimester maternal screen panel - Serum or Plasma

135

0.81

0.22

1.4

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

2.55

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.21

0.0

5.2

—

8.17

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

0.00

0.21

0.0

1.8

—

8.75

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

655

6501

1.06

0.18

8.7

5.1

4.36

4.65

mmol/l

10.95

643

6116

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

185

1.14

0.18

2.2

1.5

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

1.13

0.16

1.8

1.3

—

nmol/l

—

(3008898) HLA-B27 [Presence]

304

1.09

0.14

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

363

1.08

0.14

1.1

—

(44813793) Dust mix specific IgE antibody measurement

1.04

0.09

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1.11

0.09

1.7

1.5

144.90

184.58

pmol/l

—

(3011288) Drugs identified in Urine by Screen method Nominal

226

0.93

0.08

5.3

2.4

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.79

0.08

1.2

4.0

10.72

66.09

u/ml

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

650

6475

1.03

0.07

8.6

5.0

1.33

1.43

mmol/l

8.54

636

6057

(3043238) Trisomy 21 risk [Likelihood] in Fetus

102

0.88

0.06

1.2

1.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

193

1907

1.02

0.05

4.2

25.13

20.90

2.41

862

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

347

1.04

0.05

1.5

2.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

814

1.02

0.04

5.7

4.7

31.55

31.57

0.00

540

(3028707) Methadone [Presence] in Urine by Screen method

140

0.93

0.04

4.2

2.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

717

1.02

0.03

18.3

6.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

411

1.02

0.02

1.8

2.2

—

(40768793) Breast Pathology biopsy report

157

0.95

0.01

1.7

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

114

1.05

0.00

1.2

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

115

1.04

0.00

1.2

1.5

1.33

1.19

ratio

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

115

1.04

0.00

1.2

1.5

1.56

1.09

ratio

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

115

1.04

0.00

1.2

1.5

0.98

0.96

ratio

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

658

6575

1.01

0.00

8.8

5.7

2.46

2.75

mmol/l

15.77

643

6159

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

818

1.00

0.00

1.7

2.2

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

0.00

0.0

1.9

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.93

-0.00

1.3

1.6

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

399.71

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.85

-0.00

1.0

1.1

—

(3020491) Glucose [Moles/volume] in Blood

0.98

-0.00

6.0

1.7

9.60

6.46

mmol/l

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(40758358) Immune stain study

0.00

-0.00

0.0

1.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

470

1.00

-0.00

1.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(44806420) Estimation of glomerular filtration rate

1.01

-0.00

1.9

2.5

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

65.67

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

73.42

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

570.84

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.92

-0.00

1.2

1.5

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.00

-0.00

0.0

1.9

—

0.50

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

59.00

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3001556) Androgen free Index in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3001729) Color of Synovial fluid

0.00

-0.00

0.0

1.3

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

-0.00

0.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint CMV_NOS and mortality.

Females

Parameter	HR [95% CI]	p-value
CMV_NOS	9.487 [7.39, 12.17]	< 0.001
Birth year	0.993 [0.98, 1.0]	0.116

During the follow-up period (1.1.1998 — 31.12.2019), 357 out of 1188 females with CMV_NOS died.

Males

Parameter	HR [95% CI]	p-value
CMV_NOS	7.015 [5.52, 8.92]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.01

During the follow-up period (1.1.1998 — 31.12.2019), 461 out of 1368 males with CMV_NOS died.

Mortality risk

Mortality risk for people of age

years, who have CMV_NOS.

N-year risk	Females	Males
1	0.788%	1.214%
5	5.163%	7.644%
10	11.688%	18.808%
15	22.762%	32.33%
20	36.887%	49.928%

Relationships between endpoints

↥

Index endpoint: CMV_NOS – Other/unspecified cytomegaloviral diseases

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other/unspecified cytomegaloviral diseases

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints